Effervescence

1: Hopkins N, Reicher SD, Khan SS, Tewari S, Srinivasan N, Stevenson C.
Explaining effervescence: Investigating the relationship between shared social
identity and positive experience in crowds. Cogn Emot. 2015 Mar 19:1-13. [Epub
ahead of print] PubMed PMID: 25787295.
2: Dimond R, Bartlett A, Lewis J. What binds biosociality? The collective
effervescence of the parent-led conference. Soc Sci Med. 2015 Feb;126:1-8. doi:
10.1016/j.socscimed.2014.12.005. Epub 2014 Dec 2. PubMed PMID: 25497725.
3: Liu X, Shen Z, Wang P, Liu C, Zhou Z, Liu D. Effervescence assisted on-site
liquid phase microextraction for the determination of five triazine herbicides in
water. J Chromatogr A. 2014 Dec 5;1371:58-64. doi: 10.1016/j.chroma.2014.10.068.
Epub 2014 Oct 31. PubMed PMID: 25456587.
4: Jiang W, Chen X, Liu F, You X, Xue J. Effervescence-assisted dispersive
liquid-liquid microextraction using a solid effervescent agent as a novel
dispersion technique for the analysis of fungicides in apple juice. J Sep Sci.
2014 Nov;37(21):3157-63. doi: 10.1002/jssc.201400695. Epub 2014 Sep 22. PubMed
PMID: 25136817.
5: Lasarte-Aragonés G, Lucena R, Cárdenas S, Valcárcel M. Effervescence assisted
dispersive liquid-liquid microextraction with extractant removal by magnetic
nanoparticles. Anal Chim Acta. 2014 Jan 7;807:61-6. doi:
10.1016/j.aca.2013.11.029. Epub 2013 Nov 21. PubMed PMID: 24356221.
6: Lasarte-Aragonés G, Lucena R, Cárdenas S, Valcárcel M. Effervescence-assisted
carbon nanotubes dispersion for the micro-solid-phase extraction of triazine
herbicides from environmental waters. Anal Bioanal Chem. 2013
Apr;405(10):3269-77. doi: 10.1007/s00216-013-6718-3. Epub 2013 Jan 27. PubMed
PMID: 23354573.
7: Xygalatas D, Konvalinka I, Bulbulia J, Roepstorff A. Quantifying collective
effervescence: Heart-rate dynamics at a fire-walking ritual. Commun Integr Biol.
2011 Nov 1;4(6):735-8. PubMed PMID: 22446541; PubMed Central PMCID: PMC3306345.
8: Lasarte-Aragonés G, Lucena R, Cárdenas S, Valcárcel M. Effervescence-assisted
dispersive micro-solid phase extraction. J Chromatogr A. 2011 Dec
23;1218(51):9128-34. doi: 10.1016/j.chroma.2011.10.042. Epub 2011 Oct 21. PubMed
PMID: 22071424.
9: Liger-Belair G. Visual perception of effervescence in champagne and other
sparkling beverages. Adv Food Nutr Res. 2010;61:1-55. doi:
10.1016/B978-0-12-374468-5.00001-5. Review. PubMed PMID: 21092901.
10: Shirsand SB, Suresh S, Para MS, Swamy PV. Design of fast disintegrating
tablets of prochlorperazine maleate by effervescence method. Indian J Pharm Sci.
2009 Jul;71(4):447-51. doi: 10.4103/0250-474X.57298. PubMed PMID: 20502555;
PubMed Central PMCID: PMC2865821.
11: Raynal C, Lefebvre T. [Phamaceutical effervescence around soda water]. Rev
Hist Pharm (Paris). 2007 Jan;54(352):511-23. French. PubMed PMID: 17575845.
12: Liger-Belair G. The science of bubbly. Scientists study the nose-tickling
effervescence of champagne–an alluring and unmistakable aspect of its appeal.
Sci Am. 2003 Jan;288(1):80-5. PubMed PMID: 12506428.
13: Joachim J, Kalantzis G, Delonca H, Sabatier R, Abramovici B, Lheritier J,
Molard F. [Effervescent aspartame tablets. II. The effect of granulometry and
temperature on effervescence time and the kinetics and rate of carbon dioxide
liberation]. J Pharm Belg. 1987 Sep-Oct;42(5):303-14. French. PubMed PMID:
3123639.
14: Svec TA, Harrison JW. The effect of effervescence on debridement of the
apical regions of root canals in single-rooted teeth. J Endod. 1981
Jul;7(7):335-40. PubMed PMID: 6942090.

 

 
1: Stocchi F, Vacca L, Grassini P, Pawsey S, Whale H, Marconi S, Torti M. L-Dopa
Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus
Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised
Study. Parkinsons Dis. 2015;2015:369465. doi: 10.1155/2015/369465. Epub 2015 Jun
10. PubMed PMID: 26171276; PubMed Central PMCID: PMC4478358.
2: Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B,
Chung LY, Noordin MI. Formulation and in vitro, in vivo evaluation of
effervescent floating sustained-release imatinib mesylate tablet. PLoS One. 2015
Jun 2;10(6):e0126874. doi: 10.1371/journal.pone.0126874. eCollection 2015. PubMed
PMID: 26035710; PubMed Central PMCID: PMC4452730.
3: Qi X, Chen H, Rui Y, Yang F, Ma N, Wu Z. Floating tablets for controlled
release of ofloxacin via compression coating of hydroxypropyl cellulose combined
with effervescent agent. Int J Pharm. 2015 Jul 15;489(1-2):210-7. doi:
10.1016/j.ijpharm.2015.05.007. Epub 2015 May 5. PubMed PMID: 25956047.
4: Meka VS, Pillai S, Dharmalingham SR, Sheshala R, Gorajana A. Preparation and
in vitro characterization of a non-effervescent floating drug delivery system for
poorly soluble drug, glipizide. Acta Pol Pharm. 2015 Jan-Feb;72(1):193-204.
PubMed PMID: 25850215.
5: Rahim SA, Carter PA, Elkordy AA. Design and evaluation of effervescent
floating tablets based on hydroxyethyl cellulose and sodium alginate using
pentoxifylline as a model drug. Drug Des Devel Ther. 2015 Mar 31;9:1843-57. doi:
10.2147/DDDT.S78717. eCollection 2015. PubMed PMID: 25848220; PubMed Central
PMCID: PMC4386796.
6: Srikanth Meka V, Wee Liang VA, Dharmalingham SR, Sheshala R, Gorajana A.
Preparation and in vitro characterization of non-effervescent floating drug
delivery system of poorly soluble drug, carvedilol phosphate. Acta Pharm. 2014
Dec;64(4):485-94. doi: 10.2478/acph-2014-0038. PubMed PMID: 25531788.
7: Ye LH, Cao W, Hu SS, Da JH, Dai HB, Cao J, Xu JJ, Pang XQ.
Effervescent-salt-assisted dispersive micro-solid-phase extraction using
mesoporous hybrid materials coupled with ultra-performance liquid chromatography
for the determination of trace-level compounds in complicated plant preparations.
Anal Bioanal Chem. 2015 Feb;407(6):1763-73. doi: 10.1007/s00216-014-8396-1. Epub
2014 Dec 20. PubMed PMID: 25527130.
8: Ringe KI, Meyer S, Ringe BP, Winkler M, Wacker F, Raatschen HJ. Value of oral
effervescent powder administration for multidetector CT evaluation of esophageal
cancer. Eur J Radiol. 2015 Feb;84(2):215-20. doi: 10.1016/j.ejrad.2014.11.008.
Epub 2014 Nov 18. PubMed PMID: 25497235.
9: Khan A, Iqbal Z, Rehman Z, Nasir F, Khan A, Ismail M, Roohullah, Mohammad A.
Application of SeDeM Expert system in formulation development of effervescent
tablets by direct compression. Saudi Pharm J. 2014 Nov;22(5):433-44. doi:
10.1016/j.jsps.2013.07.002. Epub 2013 Aug 8. PubMed PMID: 25473332; PubMed
Central PMCID: PMC4246396.
10: Cooper G, Foster J, Galbraith L, Jain S, Neukermans A, Ormond B. Preliminary
results for salt aerosol production intended for marine cloud brightening, using
effervescent spray atomization. Philos Trans A Math Phys Eng Sci. 2014 Dec
28;372(2031). pii: 20140055. doi: 10.1098/rsta.2014.0055. PubMed PMID: 25404673;
PubMed Central PMCID: PMC4240953.
11: Aslani A, Sharifian T. Formulation, characterization and physicochemical
evaluation of amoxicillin effervescent tablets. Adv Biomed Res. 2014 Oct
20;3:209. doi: 10.4103/2277-9175.143252. eCollection 2014. PubMed PMID: 25371866;
PubMed Central PMCID: PMC4219208.
12: Hu Y, Ju SH, Zhang YJ, Xiong M, Xu SJ, Ma YT, Zhong ZD. [Effect of Tongluo
Xingnao effervescent tablets on learning and memory dysfunction in rats with
chronic cerebral ischemia]. Zhongguo Zhong Yao Za Zhi. 2014 May;39(10):1908-12.
Chinese. PubMed PMID: 25282904.
13: Jiang W, Chen X, Liu F, You X, Xue J. Effervescence-assisted dispersive
liquid-liquid microextraction using a solid effervescent agent as a novel
dispersion technique for the analysis of fungicides in apple juice. J Sep Sci.
2014 Nov;37(21):3157-63. doi: 10.1002/jssc.201400695. Epub 2014 Sep 22. PubMed
PMID: 25136817.
14: Nazir SR, Ambreen G, Irfan HM, Bashir S, Rauf A. Development and formulation
of metformin (Antidiabetic) effervescent Granules: to increase patient compliance
and its stability study. Pak J Pharm Sci. 2014 Jul;27(4):763-6. PubMed PMID:
25015437.
15: Invernizzi M, Cisari C, Carda S. The potential impact of new effervescent
alendronate formulation on compliance and persistence in osteoporosis treatment.
Aging Clin Exp Res. 2015 Apr;27(2):107-13. doi: 10.1007/s40520-014-0256-5. Epub
2014 Jul 5. PubMed PMID: 24996788.
16: Kriangkrai W, Puttipipatkhachorn S, Sriamornsak P, Pongjanyakul T,
Sungthongjeen S. Impact of anti-tacking agents on properties of gas-entrapped
membrane and effervescent floating tablets. AAPS PharmSciTech. 2014
Dec;15(6):1357-69. doi: 10.1208/s12249-014-0161-4. Epub 2014 Jun 14. PubMed PMID:
24927669; PubMed Central PMCID: PMC4245443.
17: Szałek E, Karbownik A, Murawa D, Połom K, Urbaniak B, Grabowski T, Wolc A,
Więckiewicz A, Grześkowiak E, Kokot ZJ, Murawa P, Burchardt P, Cieśla S. The
pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol
fixed-dose combination tablet in patients after total gastric resection.
Pharmacol Rep. 2014 Feb;66(1):159-64. doi: 10.1016/j.pharep.2013.06.010. Epub
2014 Feb 5. PubMed PMID: 24905322.
18: Jaipal A, Pandey MM, Charde SY, Sadhu N, Srinivas A, Prasad RG. Controlled
release effervescent buccal discs of buspirone hydrochloride: in vitro and in
vivo evaluation studies. Drug Deliv. 2014 Jun 3:1-7. [Epub ahead of print] PubMed
PMID: 24892624.
19: Mohammed KA, Ibrahim HK, Ghorab MM. Effervescent tablet formulation for
enhanced patient compliance and the therapeutic effect of risperidone. Drug
Deliv. 2014 May 15:1-10. [Epub ahead of print] PubMed PMID: 24833273.
20: Sánchez-Jurado R, Ferrer-Rebolleda J, Cózar-Santiago Mdel P, Aguilar-Barrios
JE, Devis-Saiz M, Sanz-Llorens R. Use of an oral effervescent agent in the
diagnostic of gastric carcinoma with 18F-FDG PET/CT. Rev Esp Enferm Dig. 2014
Jan;106(1):68-9. PubMed PMID: 24689724.
21: He LY, Zhang GL, Yan SY, Liu Y, Zhao CS, Wang XL, Li Y, Mi YQ, Liu YM, Li CP,
Kou YH, Li Y, Chang K, Meng XL, Sun XJ, Zhao T, Li J, Wang YY, Liu BY. A
double-blind comparative study of Chinese herbal medicine Jinlianqingre
Effervescent Tablets in combination with conventional therapy for the treatment
of uncomplicated hand, foot, and mouth disease. Eur J Clin Microbiol Infect Dis.
2014 Aug;33(8):1429-37. doi: 10.1007/s10096-014-2085-z. Epub 2014 Mar 19. PubMed
PMID: 24643639.
22: Paulson RJ, Collins MG, Yankov VI. Progesterone pharmacokinetics and
pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized
progesterone vaginal insert. J Clin Endocrinol Metab. 2014 Nov;99(11):4241-9.
doi: 10.1210/jc.2013-3937. Epub 2014 Feb 25. PubMed PMID: 24606090.
23: Acharya S, Patra S, Pani NR. Optimization of HPMC and carbopol concentrations
in non-effervescent floating tablet through factorial design. Carbohydr Polym.
2014 Feb 15;102:360-8. doi: 10.1016/j.carbpol.2013.11.060. Epub 2013 Dec 6.
PubMed PMID: 24507292.
24: Zhang YJ, Dai Y, Hu Y, Ma YT, Xu SJ, Wang YY. [Effect of tongluo xingnao
effervescent tablet on learning and memory of AD rats and expression of
insulin-degrading enzyme in hippocampus]. Zhongguo Zhong Yao Za Zhi. 2013
Sep;38(17):2863-7. Chinese. PubMed PMID: 24380312.
25: Miao RM, Sun XF, Zhang YY, Wu W, Fang ZH, Zhao R, Zhao DK, Qian GL, Ji J.
[Clinical efficacy of tetrandrine combined with acetylcysteine effervescent
tablets in treatment of silicosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za
Zhi. 2013 Nov;31(11):857-8. Chinese. PubMed PMID: 24370303.
26: Cansu A, Ahmetoglu A, Kul S, Yukunc G, Fidan S, Arslan M, Topbas M.
Diagnostic performance of using effervescent powder for detection and grading of
esophageal varices by multi-detector computed tomography. Eur J Radiol. 2014
Mar;83(3):497-502. doi: 10.1016/j.ejrad.2013.11.014. Epub 2013 Dec 4. PubMed
PMID: 24355657.
27: Aslani A, Jahangiri H. Formulation, characterization and physicochemical
evaluation of ranitidine effervescent tablets. Adv Pharm Bull. 2013;3(2):315-22.
doi: 10.5681/apb.2013.051. Epub 2013 Aug 20. PubMed PMID: 24312854; PubMed
Central PMCID: PMC3848210.
28: Aslani A, Fattahi F. Formulation, characterization and physicochemical
evaluation of potassium citrate effervescent tablets. Adv Pharm Bull.
2013;3(1):217-25. doi: 10.5681/apb.2013.036. Epub 2013 Feb 7. PubMed PMID:
24312839; PubMed Central PMCID: PMC3846033.
29: George J, Majeed W, Mackenzie IS, Macdonald TM, Wei L. Association between
cardiovascular events and sodium-containing effervescent, dispersible, and
soluble drugs: nested case-control study. BMJ. 2013 Nov 26;347:f6954. doi:
10.1136/bmj.f6954. PubMed PMID: 24284017; PubMed Central PMCID: PMC3898660.
30: Guo SS, Gao YJ, Tian XC, Jin YH, Liu FZ, Cui XL. [Effect of xuebijing oral
effervescent tablet on endotoxin induced fever and disseminated intravascular
coagulation rabbit model]. Yao Xue Xue Bao. 2013 Aug;48(8):1241-6. Chinese.
PubMed PMID: 24187830.
31: Wei Y, Xue Z, Ye Y, Huang Y, Zhao L. Paclitaxel targeting to lungs by way of
liposomes prepared by the effervescent dispersion technique. Arch Pharm Res. 2014
Jun;37(6):728-37. doi: 10.1007/s12272-013-0181-8. Epub 2013 Jun 18. PubMed PMID:
23775475.
32: Wabaidur SM, Alothman ZA, Khan MR. A rapid method for the simultaneous
determination of L-ascorbic acid and acetylsalicylic acid in aspirin C
effervescent tablet by ultra performance liquid chromatography-tandem mass
spectrometry. Spectrochim Acta A Mol Biomol Spectrosc. 2013 May;108:20-5. doi:
10.1016/j.saa.2013.01.070. Epub 2013 Feb 6. PubMed PMID: 23454710.
33: Figueroa CE, Adamson DH, Prud’homme RK. Effervescent redispersion of
lyophilized polymeric nanoparticles. Ther Deliv. 2013 Feb;4(2):177-90. doi:
10.4155/tde.12.138. PubMed PMID: 23343158.
34: Getyala A, Gangadharappa HV, Prasad MS, Reddy MP, Kumar TM. Formulation and
evaluation of non-effervescent floating tablets of losartan potassium. Curr Drug
Deliv. 2013 Oct;10(5):620-9. PubMed PMID: 23286884.
35: Niederhauser BD, Atwell TD, MacCarty RL, Bender CE. Gas-containing gallstones
as a cause of the “effervescent gallbladder” sign and pneumobilia. J Clin
Ultrasound. 2013 Nov-Dec;41 Suppl 1:50-3. doi: 10.1002/jcu.22020. Epub 2012 Dec
1. PubMed PMID: 23203480.
36: In brief: effervescent alendronate. Med Lett Drugs Ther. 2012 Oct
15;54(1401):84. PubMed PMID: 23059422.
37: Yao XQ, Zhang YH, Sun CH. [Protective effects of Xuebijing effervescent
tablet on vital organs in rats with toxic injury induced by endotoxin]. Zhongguo
Wei Zhong Bing Ji Jiu Yi Xue. 2012 Jun;24(6):357-9. Chinese. PubMed PMID:
23019734.
38: Al-Hallak MH, Sarfraz MK, Azarmi S, Roa WH, Finlay WH, Rouleau C, Löbenberg
R. Distribution of effervescent inhalable nanoparticles after pulmonary delivery:
an in vivo study. Ther Deliv. 2012 Jun;3(6):725-34. PubMed PMID: 22838068.
39: Vötsch A, Beran E, Zirngast B, Mächler H. Re-sternotomy as an unwelcome
side-effect of unknown effervescent tablet intake? Interact Cardiovasc Thorac
Surg. 2012 Sep;15(3):558-9. doi: 10.1093/icvts/ivs183. Epub 2012 May 22. PubMed
PMID: 22617503; PubMed Central PMCID: PMC3422925.
40: Hodges LA, Connolly SM, Winter J, Schmidt T, Stevens HN, Hayward M, Wilson
CG. Modulation of gastric pH by a buffered soluble effervescent formulation: A
possible means of improving gastric tolerability of alendronate. Int J Pharm.
2012 Aug 1;432(1-2):57-62. doi: 10.1016/j.ijpharm.2012.04.073. Epub 2012 May 4.
PubMed PMID: 22564778.
41: Meka VS, Songa AS, Nali SR, Battu JR, Kolapalli VR. Design and in vitro
evaluation of effervescent gastric floating drug delivery systems of propanolol
HCl. Invest Clin. 2012 Mar;53(1):60-70. PubMed PMID: 22524109.
42: Sakhaee K, Pak C. Superior calcium bioavailability of effervescent potassium
calcium citrate over tablet formulation of calcium citrate after Roux-en-Y
gastric bypass. Surg Obes Relat Dis. 2013 Sep-Oct;9(5):743-8. doi:
10.1016/j.soard.2011.11.011. Epub 2011 Dec 3. PubMed PMID: 22222299.
43: Wening K, Laukamp EJ, Thommes M, Breitkreutz J. Individual oral therapy with
immediate release and effervescent formulations delivered by the solid dosage
pen. J Pers Med. 2012 Nov 6;2(4):217-31. doi: 10.3390/jpm2040217. PubMed PMID:
25562361; PubMed Central PMCID: PMC4251373.
44: Negi JS, Trivedi A, Khanduri P, Negi V, Kasliwal N. Effect of bioadhesion on
initial in vitro buoyancy of effervescent floating matrix tablets of
ciprofloxacin HCL. J Adv Pharm Technol Res. 2011 Apr;2(2):121-7. doi:
10.4103/2231-4040.82954. PubMed PMID: 22171304; PubMed Central PMCID: PMC3217692.
45: Yamada T, Inoue Y, Asano Y, Nippashi Y, Woodhams R, Matsunaga K, Tago M. Use
of an oral effervescent agent in the evaluation of gastric 67Ga uptake. Ann Nucl
Med. 2012 Feb;26(2):192-6. doi: 10.1007/s12149-011-0554-3. Epub 2011 Nov 15.
PubMed PMID: 22081275.
46: Zheng P, Meng LJ, Sun GP, Wang WZ. [Study on optimization of formulation of
Danggui Liuhuang effervescent granules]. Zhong Yao Cai. 2011 Mar;34(3):452-5.
Chinese. PubMed PMID: 21823466.
47: Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, Mohrbacher
R, Levitt M, Greinwald R, Shapira MY. Improvement in oral chronic
graft-versus-host disease with the administration of effervescent tablets of
topical budesonide-an open, randomized, multicenter study. Biol Blood Marrow
Transplant. 2012 Jan;18(1):134-40. doi: 10.1016/j.bbmt.2011.06.001. Epub 2011 Jun
12. PubMed PMID: 21703973.
48: Someshwar K, Chithaluru K, Ramarao T, Kumar KK. Formulation and evaluation of
effervescent floating tablets of tizanidine hydrochloride. Acta Pharm. 2011
Jun;61(2):217-26. doi: 10.2478/v10007-011-0015-5. PubMed PMID: 21684848.
49: Maximiano FP, Costa GH, de Sá Barreto LC, Bahia MT, Cunha-Filho MS.
Development of effervescent tablets containing benzonidazole complexed with
cyclodextrin. J Pharm Pharmacol. 2011 Jun;63(6):786-93. doi:
10.1111/j.2042-7158.2011.01284.x. Epub 2011 May 3. PubMed PMID: 21585376.
50: Bani-Jaber AK, Alkawareek MY, Al-Gousous JJ, Abu Helwa AY. Floating and
sustained-release characteristics of effervescent tablets prepared with a mixed
matrix of Eudragit L-100-55 and Eudragit E PO. Chem Pharm Bull (Tokyo).
2011;59(2):155-60. PubMed PMID: 21297292.
51: Shirsand SB, Suresh S, Jodhana LS, Swamy PV. Formulation design and
optimization of fast disintegrating Lorazepam tablets by effervescent method.
Indian J Pharm Sci. 2010 Jul;72(4):431-6. doi: 10.4103/0250-474X.73911. PubMed
PMID: 21218052; PubMed Central PMCID: PMC3013557.
52: Gande S, Rao Y. Sustained-release effervescent floating matrix tablets of
baclofen: development, optimization and in vitro-in vivo evaluation in healthy
human volunteers. Daru. 2011;19(3):202-9. PubMed PMID: 22615658; PubMed Central
PMCID: PMC3232112.
53: Liu YM, Liu Y, Lu C, Jia JY, Liu GY, Weng LP, Wang JY, Li GX, Wang W, Li SJ,
Yu C. Relative bioavailability of generic and branded acetylcysteine effervescent
tablets: A single-dose, open-label, randomized-sequence, two-period crossover
study in fasting healthy Chinese male volunteers. Clin Ther. 2010
Nov;32(12):2097-105. doi: 10.1016/j.clinthera.2010.11.001. PubMed PMID: 21118745.
54: Yeniocak S, Tatli O, Cansu A, Erturk E, Erol MM, Turedi S. Acute severe
respiratory distress secondary to misuse of an N-acetylcysteine effervescent
tablet. Am J Emerg Med. 2010 Sep;28(7):842.e5-6. doi: 10.1016/j.ajem.2009.11.013.
Epub 2010 Apr 2. PubMed PMID: 20837268.
55: Stocchi F, Zappia M, Dall’Armi V, Kulisevsky J, Lamberti P, Obeso JA;
Melevodopa Plus Carbidopa Study Group. Melevodopa/carbidopa effervescent
formulation in the treatment of motor fluctuations in advanced Parkinson’s
disease. Mov Disord. 2010 Sep 15;25(12):1881-7. doi: 10.1002/mds.23206. PubMed
PMID: 20669296.
56: de Andrade IM, Cruz PC, da Silva CH, de Souza RF, Paranhos Hde F, Candido RC,
Marin JM, de Souza-Gugelmin MC. Effervescent tablets and ultrasonic devices
against Candida and mutans streptococci in denture biofilm. Gerodontology. 2011
Dec;28(4):264-70. doi: 10.1111/j.1741-2358.2010.00378.x. Epub 2010 May 26. PubMed
PMID: 20518813.
57: Zhao L, Wei Y, Li W, Liu Y, Wang Y, Zhong X, Yu Y. Solid dispersion and
effervescent techniques used to prepare docetaxel liposomes for lung-targeted
delivery system: in vitro and in vivo evaluation. J Drug Target. 2011
Apr;19(3):171-8. doi: 10.3109/10611861003801859. Epub 2010 Apr 30. PubMed PMID:
20429774.
58: He Y, Xin H, Huang K, Zhang Y, Luo X. [Effect of alcohol concentration in
water extraction and alcohol precipitation on preparation of effervescent tablets
of Banlangen]. Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(3):288-92. Chinese. PubMed
PMID: 20422990.
59: Gauniya A, Das S, Mallick S, Basu SP. Comparative bioavailability studies of
citric acid and malonic acid based aspirin effervescent tablets. J Pharm
Bioallied Sci. 2010 Apr;2(2):118-20. doi: 10.4103/0975-7406.67015. PubMed PMID:
21814444; PubMed Central PMCID: PMC3147094.
60: Swamy PV, Divate SP, Shirsand SB, Rajendra P. Preparation and evaluation of
orodispersible tablets of pheniramine maleate by effervescent method. Indian J
Pharm Sci. 2009 Mar;71(2):151-4. doi: 10.4103/0250-474X.54284. PubMed PMID:
20336216; PubMed Central PMCID: PMC2839404.
61: Nagendrakumar D, Raju SA, Shirsand SB, Para MS, Rampure MV. Fast Dissolving
Tablets of Fexofenadine HCl by Effervescent Method. Indian J Pharm Sci. 2009
Mar;71(2):116-9. doi: 10.4103/0250-474X.54272. PubMed PMID: 20336204; PubMed
Central PMCID: PMC2839392.
62: Rajab M, Jouma M, Neubert RH, Dittgen M. Optimization of a metformin
effervescent floating tablet containing hydroxypropylmethylcellulose and stearic
acid. Pharmazie. 2010 Feb;65(2):97-101. PubMed PMID: 20225651.
63: Tadros MI. Controlled-release effervescent floating matrix tablets of
ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo
evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010
Feb;74(2):332-9. doi: 10.1016/j.ejpb.2009.11.010. Epub 2009 Nov 22. PubMed PMID:
19932750.
64: Fentanyl effervescent buccal tablets: new formulation. For cancer patients
with breakthrough pain: a second buccal formulation with minimal evaluation.
Prescrire Int. 2009 Oct;18(103):205. PubMed PMID: 19882786.
65: Ibrahim HK. A novel liquid effervescent floating delivery system for
sustained drug delivery. Drug Discov Ther. 2009 Aug;3(4):168-75. PubMed PMID:
22495603.
66: Xue L, Li Y, Guo D, Yin J, Liu Y, Hou S. [Study on preparation and release
mechanism of effervescent osmotic pump tablet of compound Danshen]. Zhongguo
Zhong Yao Za Zhi. 2009 Apr;34(7):848-51. Chinese. PubMed PMID: 19623978.
67: Ubeda A, Llopico J, Sanchez MT. Blood pressure reduction in hypertensive
patients after withdrawal of effervescent medication. Pharmacoepidemiol Drug Saf.
2009 May;18(5):417-9. doi: 10.1002/pds.1701. PubMed PMID: 19248080.
68: Pisani MX, Silva-Lovato CH, Malheiros-Segundo Ade L, Macedo AP, Paranhos HF.
Bond strength and degree of infiltration between acrylic resin denture liner
after immersion in effervescent denture cleanser. J Prosthodont. 2009
Feb;18(2):123-9. doi: 10.1111/j.1532-849X.2008.00380.x. Epub 2008 Oct 20. PubMed
PMID: 19178623.
69: Jacob S, Shirwaikar A, Nair A. Preparation and evaluation of
fast-disintegrating effervescent tablets of glibenclamide. Drug Dev Ind Pharm.
2009 Mar;35(3):321-8. doi: 10.1080/03639040802337021 . PubMed PMID: 18821151.
70: Azarmi S, Lobenberg R, Roa WH, Tai S, Finlay WH. Formulation and in vivo
evaluation of effervescent inhalable carrier particles for pulmonary delivery of
nanoparticles. Drug Dev Ind Pharm. 2008 Sep;34(9):943-7. doi:
10.1080/03639040802149079 . PubMed PMID: 18800255.
71: Luo XJ, Xin HL, Rao XY, Xiao ZQ, Gao LL, Sun TT, Guo QL. [Review of
effervescent technique in pharmaceutics research]. Zhongguo Zhong Yao Za Zhi.
2008 Apr;33(8):973-6. Review. Chinese. PubMed PMID: 18619362.
72: Jin GY, Park SH, Han YM. Usefulness of MDCT evaluation of the intraluminal
surface of esophageal masses using only effervescent powder without injection of
hypotonic agent. Abdom Imaging. 2009 Jul;34(4):424-9. doi:
10.1007/s00261-008-9398-2. PubMed PMID: 18493816.
73: Améndola R, Santos MC, Massa JM, Vazquez H, Smecuol E. Effects of a single
low dose of ranitidine and effervescent antacids on intragastric acidity in
healthy volunteers. Acta Gastroenterol Latinoam. 2007 Dec;37(4):231-7. PubMed
PMID: 18254261.
74: Freye E. A new transmucosal drug delivery system for patients with
breakthrough cancer pain: the fentanyl effervescent buccal tablet. J Pain Res.
2008 Dec 17;2:13-20. PubMed PMID: 21197291; PubMed Central PMCID: PMC3004632.
75: Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of
breakthrough pain in patients compared to immediate release morphine sulfate
tablet. Pain Pract. 2007 Dec;7(4):324-31. Epub 2007 Nov 6. PubMed PMID: 17986159.
76: Di Girolamo G, Opezzo JA, Lopez MI, Schere D, Keller G, Gonzalez CD, Massa
JM, de los Santos MC. Relative bioavailability of new formulation of paracetamol
effervescent powder containing sodium bicarbonate versus paracetamol tablets: a
comparative pharmacokinetic study in fed subjects. Expert Opin Pharmacother. 2007
Oct;8(15):2449-57. PubMed PMID: 17931082.
77: Wang L, Tang X. A novel ketoconazole bioadhesive effervescent tablet for
vaginal delivery: design, in vitro and ‘in vivo’ evaluation. Int J Pharm. 2008
Feb 28;350(1-2):181-7. Epub 2007 Aug 31. PubMed PMID: 17920795.
78: Getia M, Murtazashvili M, Bakuridze A, Jokhadze M, Kuchukhidze J. Production
of effervescent tablets Mucomali from polysaccharides of Malva Silvestris L.
Georgian Med News. 2007 Apr;(145):90-4. PubMed PMID: 17525511.
79: Wiwattanapatapee R, Chumthong A, Pengnoo A, Kanjanamaneesathian M.
Effervescent fast-disintegrating bacterial formulation for biological control of
rice sheath blight. J Control Release. 2007 Jun 4;119(2):229-35. Epub 2007 Feb 2.
PubMed PMID: 17428569.
80: Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000 mg effervescent
aspirin: individual patient data meta-analysis of three trials in migraine
headache and migraine accompanying symptoms. J Neurol. 2007 Jun;254(6):705-12.
Epub 2007 Apr 10. PubMed PMID: 17406776.
81: Hesaraki S, Moztarzadeh F, Sharifi D. Formation of interconnected macropores
in apatitic calcium phosphate bone cement with the use of an effervescent
additive. J Biomed Mater Res A. 2007 Oct;83(1):80-7. PubMed PMID: 17380498.
82: Zheng P, Wang WZ, Zhang P, Han J, Wu LZ. [Optimization of preparative
technique for banxia-houpu effervescent tablets by orthogonal design]. Zhong Yao
Cai. 2006 Oct;29(10):1087-90. Chinese. PubMed PMID: 17326411.
83: Stocchi F, Fabbri L, Vecsei L, Krygowska-Wajs A, Monici Preti PA, Ruggieri
SA. Clinical efficacy of a single afternoon dose of effervescent
levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease. Clin
Neuropharmacol. 2007 Jan-Feb;30(1):18-24. PubMed PMID: 17272966.
84: Hesaraki S, Sharifi D. Investigation of an effervescent additive as porogenic
agent for bone cement macroporosity. Biomed Mater Eng. 2007;17(1):29-38. PubMed
PMID: 17264385.
85: Ely L, Roa W, Finlay WH, Löbenberg R. Effervescent dry powder for respiratory
drug delivery. Eur J Pharm Biopharm. 2007 Mar;65(3):346-53. Epub 2006 Nov 7.
PubMed PMID: 17156987.
86: Parr MK, Geyer H, Hoffmann B, Köhler K, Mareck U, Schänzer W. High amounts of
17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary
supplement market. Biomed Chromatogr. 2007 Feb;21(2):164-8. PubMed PMID:
17146762.
87: Hesaraki S, Moztarzadeh F, Solati-Hashjin M. Phase evaluation of an
effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B
Appl Biomater. 2006 Nov;79(2):203-9. PubMed PMID: 16924623.
88: Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus
Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center
taste preference study. Paediatr Drugs. 2006;8(4):265-70. PubMed PMID: 16898856.
89: Darwish M, Tempero K, Kirby M, Thompson J. Relative bioavailability of the
fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal
fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a
single-dose, randomized, open-label, three-period study in healthy adult
volunteers. Clin Ther. 2006 May;28(5):715-24. PubMed PMID: 16861093.
90: Darwish M, Kirby M, Robertson P Jr, Tracewell W, Jiang JG. Pharmacokinetic
properties of fentanyl effervescent buccal tablets: a phase I, open-label,
crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult
volunteers. Clin Ther. 2006 May;28(5):707-14. PubMed PMID: 16861092.
91: Sung HH, Laborde-Kummer E, Gaudin K, Dubost JP. Development and validation of
a capillary electrophoresis method for the determination of sulfate in
effervescent tablets. Eur J Pharm Biopharm. 2006 Aug;64(1):33-7. Epub 2006 Jun 5.
PubMed PMID: 16750356.
92: Nielsen AF, Poul B, Kristensen HG, Kristensen J, Hovgaard L. Investigation
and comparison of performance of effervescent and standard pneumatic atomizer
intended for soluble aqueous coating. Pharm Dev Technol. 2006;11(2):243-53.
PubMed PMID: 16749535.
93: Stepanek F, Loo A, Lim TS. Multiscale modelling methodology for virtual
prototyping of effervescent tablets. J Pharm Sci. 2006 Jul;95(7):1614-25. PubMed
PMID: 16732565.
94: Good BT, Bowman CN, Davis RH. An effervescent reaction micropump for portable
microfluidic systems. Lab Chip. 2006 May;6(5):659-66. Epub 2006 Mar 20. PubMed
PMID: 16652182.
95: Darwish M, Tempero K, Kirby M, Thompson J. Pharmacokinetics and dose
proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
Clin Pharmacokinet. 2005;44(12):1279-86. PubMed PMID: 16372825.
96: Benting DG, Pesun IJ, Hodges J. Compliance of resilient denture liners
immersed in effervescent denture cleansers. J Prosthodont. 2005 Sep;14(3):175-83.
PubMed PMID: 16336235.
97: Hu L, Zheng J, Shao S. [Study on the preparation of effervescent tablets of
EGb and its quality]. Zhong Yao Cai. 2005 Jan;28(1):52-4. Chinese. PubMed PMID:
15934243.
98: Dinç E, Ozdemir A, Baleanu D. Comparative study of the continuous wavelet
transform, derivative and partial least squares methods applied to the
overlapping spectra for the simultaneous quantitative resolution of ascorbic acid
and acetylsalicylic acid in effervescent tablets. J Pharm Biomed Anal. 2005 Mar
9;37(3):569-75. Epub 2004 Dec 22. PubMed PMID: 15740918.
99: Lee J, Anderson R. Best evidence topic report. Effervescent agents for
oesophageal food bolus impaction. Emerg Med J. 2005 Feb;22(2):123-4. Review.
PubMed PMID: 15662067; PubMed Central PMCID: PMC1726678.
100: Munn S. The way to a man’s heart is through his stomach: much
‘diaphragmatic’ attenuation is likely gastric, and effervescent granules enhance
cardiac imaging. Eur J Radiol. 2004 Dec;52(3):271-5. Erratum in: Eur J Radiol.
2005 May;54(2):316. PubMed PMID: 15544905.
101: Tian XF, Bian BL. [Development of effervescent tablet of Chinese traditional
medicine and its technology study]. Zhongguo Zhong Yao Za Zhi. 2004
Jul;29(7):624-7. Review. Chinese. PubMed PMID: 15503761.
102: Dinç E, Ozdemir A. Multivariate spectral calibration technique based on
regression analysis for the quantitative multiresolution of a ternary mixture
containing paracetamol, ascorbic acid and acetylsalicylic acid in effervescent
tablets. Pharmazie. 2004 Sep;59(9):700-5. PubMed PMID: 15497752.
103: Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai
V, Göbel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller-Schwefe G, Nappi
G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M; EMSASI Study Group.
Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan
and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004
Nov;24(11):947-54. PubMed PMID: 15482357.
104: Rey E, Poves-Francés C, Sánchez G, Fueyo A, Badiola C, Díaz-Rubio M. Effects
of effervescent ranitidine on gastric pH: comparison with almagate and placebo in
fasting and postprandial conditions. Aliment Pharmacol Ther. 2004 Sep
15;20(6):683-8. PubMed PMID: 15352917.
105: Diener HC, Eikermann A, Gessner U, Göbel H, Haag G, Lange R, May A,
Müller-Schwefe G, Voelker M. Efficacy of 1,000 mg effervescent acetylsalicylic
acid and sumatriptan in treating associated migraine symptoms. Eur Neurol.
2004;52(1):50-6. Epub 2004 Jul 5. PubMed PMID: 15240983.
106: Li XD, Pan WS, Nie SF, Wu LJ. Studies on controlled release effervescent
osmotic pump tablets from Traditional Chinese Medicine Compound Recipe. J Control
Release. 2004 May 18;96(3):359-67. PubMed PMID: 15120893.
107: Petersen FJ, Wørts O, Schaefer T, Sojka PE. Design and atomization
properties for an inside-out type effervescent atomizer. Drug Dev Ind Pharm. 2004
Mar;30(3):319-26. PubMed PMID: 15109031.
108: Falk DJ, Heelan KA, Thyfault JP, Koch AJ. Effects of effervescent creatine,
ribose, and glutamine supplementation on muscular strength, muscular endurance,
and body composition. J Strength Cond Res. 2003 Nov;17(4):810-6. PubMed PMID:
14636104.
109: Sawyer M, Kumar V. A rapid high-performance liquid chromatographic method
for the simultaneous quantitation of aspirin, salicylic acid, and caffeine in
effervescent tablets. J Chromatogr Sci. 2003 Sep;41(8):393-7. PubMed PMID:
14558930.
110: Ganguly S, Jayappa S, Dash AK. Evaluation of the stability of creatine in
solution prepared from effervescent creatine formulations. AAPS PharmSciTech.
2003;4(2):E25. PubMed PMID: 12916907; PubMed Central PMCID: PMC2750587.
111: Ma YM, Qiu FR, Mao GG, Zeng ZH, Chen B, Sun H. [Relative bioavailability of
effervescent tablet of potassium chloride in healthy volunteers]. Yao Xue Xue
Bao. 2001 Sep;36(9):699-702. Chinese. PubMed PMID: 12580112.
112: Verschuren F, Thys F, Wittebole X, Janssens P, Elgariani A, Marion E, Meert
P, Wallemacq P, Hantson P, Reynaert M. Effervescent paracetamol poisoning: a case
report. Eur J Emerg Med. 2002 Dec;9(4):339-41. PubMed PMID: 12501034.
113: Zikán V, Roubal P, Stĕpán J. [Acute biochemical effects of calcium:
comparison of two dosage forms of calcium carbonate (powder and effervescent
tablets) and milk in healthy women]. Cas Lek Cesk. 2002 Mar 1;141(4):127-31.
Czech. PubMed PMID: 12046257.
114: Wildgrube HJ, Kierschke G, Nowak H, Weigmann I, Terhaag B. [Application of
quantifying scoring systems for the determination of changes in the mucosa of the
upper gastrointestinal tract. A comparative study of a diclofenac effervescent
tablet with conventional diclofenac preparations and acetylsalicylic acid after
repeated administration]. Arzneimittelforschung. 2002;52(4):264-72. German.
PubMed PMID: 12040969.
115: Karasulu HY, Taneri F, Sanal E, Güneri T, Ertan G. Sustained release
bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal
delivery. J Microencapsul. 2002 May-Jun;19(3):357-62. PubMed PMID: 12022501.
116: Jakus J, Kriska T, Vanyúr R. Effect of multivitamins in an effervescent
preparation on the respiratory burst of peritoneal macrophages in mice. Br J
Nutr. 2002 May;87(5):501-8. PubMed PMID: 12010588.
117: Belpois Duchamp C, Le Coq M, Bergeal E, Duez JM, Aho LS. Could an
effervescent tablet, prepared with contaminated [correction of contamined] water,
create an aerosol containing Legionella? J Hosp Infect. 2002 May;51(1):77. PubMed
PMID: 12009829.
118: Gohel MC, Sumitra G M. Modulation of active pharmaceutical material release
from a novel ‘tablet in capsule system’ containing an effervescent blend. J
Control Release. 2002 Feb 19;79(1-3):157-64. PubMed PMID: 11853927.
119: Park TG. Perfusion culture of hepatocytes within galactose-derivatized
biodegradable poly(lactide-co-glycolide) scaffolds prepared by gas foaming of
effervescent salts. J Biomed Mater Res. 2002 Jan;59(1):127-35. PubMed PMID:
11745545.
120: Van Poucke S, Hans G, Hens P. The release of dissolved gases from solution
during decompression after hyperbaric treatment: effervescent tables and Henry’s
law. Anesthesiology. 2001 Sep;95(3):816. PubMed PMID: 11575571.
121: Petersen FJ, Wørts O, Schaefer T, Sojka PE. Effervescent atomization of
aqueous polymer solutions and dispersions. Pharm Dev Technol. 2001;6(2):201-10.
PubMed PMID: 11416994.
122: Yanze MF, Duru C, Jacob M, Bastide JM, Lankeuh M. Rapid therapeutic response
onset of a new pharmaceutical form of chloroquine phosphate 300 mg: effervescent
tablets. Trop Med Int Health. 2001 Mar;6(3):196-201. PubMed PMID: 11299036.
123: Yoon JJ, Park TG. Degradation behaviors of biodegradable macroporous
scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 2001
Jun 5;55(3):401-8. PubMed PMID: 11255194.
124: Yanze FM, Duru C, Jacob M. Process to manufacture effervescent tablets: air
forced oven melt granulation. Pharmazie. 2000 Dec;55(12):919-24. PubMed PMID:
11189868.
125: Lange R, Schwarz JA, Hohn M. Acetylsalicylic acid effervescent 1000 mg
(Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind,
single-dose, placebo-controlled parallel group study. Cephalalgia. 2000
Sep;20(7):663-7. PubMed PMID: 11128825.
126: Terhaag B, Hoffmann A, Barkworth M, Vens-Cappell B. Bioavailability of a new
effervescent tablet of diclofenac. Int J Clin Pharmacol Ther. 2000
Nov;38(11):546-51. PubMed PMID: 11097147.
127: Yanze FM, Duru C, Jacob M. A process to produce effervescent tablets:
fluidized bed dryer melt granulation. Drug Dev Ind Pharm. 2000
Nov;26(11):1167-76. PubMed PMID: 11068690.
128: Earnest D, Robinson M, Rodriguez-Stanley S, Ciociola AA, Jaffe P, Silver MT,
Kleoudis CS, Murdock RH. Managing heartburn at the ‘base’ of the GERD ‘iceberg’:
effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief
than antacids. Aliment Pharmacol Ther. 2000 Jul;14(7):911-8. PubMed PMID:
10886047.
129: Săndulescu R, Mirel S, Oprean R. The development of spectrophotometric and
electroanalytical methods for ascorbic acid and acetaminophen and their
applications in the analysis of effervescent dosage forms. J Pharm Biomed Anal.
2000 Aug 1;23(1):77-87. PubMed PMID: 10898157.
130: Rygnestad T, Zahlsen K, Samdal FA. Absorption of effervescent paracetamol
tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J
Clin Pharmacol. 2000 May;56(2):141-3. PubMed PMID: 10877008.
131: Yanze MF, Duru C, Jacob M, Gasc F. [The carbon dioximeter: a device for
quantifying the carbon dioxide released from effervescent pharmaceuticals]. J
Pharm Belg. 2000 Mar-Apr;55(2):53-6. French. PubMed PMID: 10842927.
132: Møller PL, Nørholt SE, Ganry HE, Insuasty JH, Vincent FG, Skoglund LA,
Sindet-Pedersen S. Time to onset of analgesia and analgesic efficacy of
effervescent acetaminophen 1000 mg compared to tablet acetaminophen 1000 mg in
postoperative dental pain: a single-dose, double-blind, randomized,
placebo-controlled study. J Clin Pharmacol. 2000 Apr;40(4):370-8. PubMed PMID:
10761164.
133: Le Coz CJ, Bezard M. Allergic contact cheilitis due to effervescent dental
cleanser: combined responsibilities of the allergen persulfate and prosthesis
porosity. Contact Dermatitis. 1999 Nov;41(5):268-71. PubMed PMID: 10554061.
134: Krögel I, Bodmeier R. Floating or pulsatile drug delivery systems based on
coated effervescent cores. Int J Pharm. 1999 Oct 5;187(2):175-84. PubMed PMID:
10502623.
135: Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP,
Scarpignato C. Effects of tablet and effervescent formulations of ranitidine 75
mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in
healthy humans. Aliment Pharmacol Ther. 1998 Nov;12(11):1155-61. PubMed PMID:
9845405.
136: Elm M, Hellke P, Andrén K, Dahl G, Nyth AL. Time to relief of episodic
symptoms of gastro-oesophageal reflux disease. A crossover comparison of single
doses of the effervescent and standard formulations of ranitidine. Scand J
Gastroenterol. 1998 Sep;33(9):900-4. PubMed PMID: 9759942.
137: Rotthäuser B, Kraus G, Schmidt PC. Optimization of an effervescent tablet
formulation containing spray dried L-leucine and polyethylene glycol 6000 as
lubricants using a central composite design. Eur J Pharm Biopharm. 1998
Jul;46(1):85-94. PubMed PMID: 9700026.
138: Hedenström H, Alm C, Kraft M, Grahnén A. Intragastric pH after oral
administration of single doses of ranitidine effervescent tablets, omeprazole
capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Aliment Pharmacol Ther. 1997 Dec;11(6):1137-41. PubMed PMID: 9663842.
139: Reilly TG, Grimley CE, Usselmann B, Cottrell J, Mann SG, Raskin S, Nwokolo
CU. Low-dose famotidine and effervescent cimetidine in healthy subjects: a
placebo-controlled overnight pH study. Aliment Pharmacol Ther. 1998
May;12(5):469-74. PubMed PMID: 9663728.
140: Merckle P, Kovar KA. Assay of effervescent tablets by near-infrared
spectroscopy in transmittance and reflectance mode: acetylsalicylic acid in mono
and combination formulations. J Pharm Biomed Anal. 1998 Jul;17(3):365-74. PubMed
PMID: 9656145.
141: Eichman JD, Robinson JR. Mechanistic studies on effervescent-induced
permeability enhancement. Pharm Res. 1998 Jun;15(6):925-30. PubMed PMID: 9647360.
142: Wu CS, Yao WJ, Hsiao CH. Effervescent gallbladder: sonographic findings in
emphysematous cholecystitis. J Clin Ultrasound. 1998 Jun;26(5):272-5. PubMed
PMID: 9608373.
143: Berlin I, Decroix D, Molinier P, Herrmann MA, Peraudeau P, Scheck F.
[Comparison between effects of morning and evening administration of effervescent
calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa
in healthy volunteers]. Pathol Biol (Paris). 1997 Jun;45(6):514-20. French.
PubMed PMID: 9309270.
144: Engzelius JM, Solhaug JH, Knapstad LJ, Kjaersgaard P. Ranitidine
effervescent and famotidine wafer in the relief of episodic symptoms of
gastro-oesophageal reflux disease. Scand J Gastroenterol. 1997 Jun;32(6):513-8.
PubMed PMID: 9200279.
145: Arnestad JS, Kleveland PM, Waldum HL. In single doses ranitidine
effervescent is more effective than lansoprazole in decreasing gastric acidity.
Aliment Pharmacol Ther. 1997 Apr;11(2):355-8. PubMed PMID: 9146775.
146: Altomare E, Vendemiale G, Benvenuti C, Andreatta P. Bioavailability of a new
effervescent tablet of ibuprofen in healthy volunteers. Eur J Clin Pharmacol.
1997;52(6):505-6. PubMed PMID: 9342589.
147: Hummel T, Cramer O, Mohammadian P, Geisslinger G, Pauli E, Kobal G.
Comparison of the antinociception produced by two oral formulations of ibuprofen:
ibuprofen effervescent vs ibuprofen tablets. Eur J Clin Pharmacol.
1997;52(2):107-14. PubMed PMID: 9174679.
148: Watson RG, Johnston BT, Tham TC, Kersey K. Effervescent and standard
formulations of ranitidine–a comparison of their pharmacokinetics and
pharmacology. Aliment Pharmacol Ther. 1996 Dec;10(6):913-8. PubMed PMID: 8971288.
149: Kovács-Hadady K, Fábián I. Determination of vitamin C in effervescent
tablets containing other vitamins together with trace elements. J Pharm Biomed
Anal. 1996 Aug;14(11):1479-86. PubMed PMID: 8877853.
150: Propst A, Propst T, Judmaier G. Comparison of the effects of ranitidine
effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric
acidity. A single-centre, randomised, open cross-over study.
Arzneimittelforschung. 1996 Jun;46(6):621-4. PubMed PMID: 8767354.
151: Stacey JH, Miocevich ML, Sacks GE. The effect of ranitidine (as effervescent
tablets) on the quality of life of GORD patients. Br J Clin Pract. 1996
Jun;50(4):190-4, 196. PubMed PMID: 8759564.
152: Sun X, Zhang Z, Ma L, Zhang W. [Extraction technology of effervescent
granules for arresting cold pain optimized by orthogonal tests]. Zhongguo Zhong
Yao Za Zhi. 1996 Mar;21(3):159-61, 190. Chinese. PubMed PMID: 9206256.
153: Vatier J, Cai S, Slama A, Farinotti R. [Antacid activity of
citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro
analysis using ‘artificial stomach-duodenum’ model]. Therapie. 1996
Mar-Apr;51(2):139-46. French. PubMed PMID: 8763048.
154: Katare OP, Vyas SP, Dixit VK. Enhanced in vivo performance of liposomal
indomethacin derived from effervescent granule based proliposomes. J
Microencapsul. 1995 Sep-Oct;12(5):487-93. PubMed PMID: 8544092.
155: Levine MS. How concerned should radiologists be about perforating the
esophagus by administering an effervescent agent during a barium swallow to treat
a foreign body impacted in the distal esophagus? AJR Am J Roentgenol. 1995
Aug;165(2):480-1. PubMed PMID: 7618582.
156: Schütze K, Hentschel E, Happonen P, Akkila J. Sucralfate effervescent
tablet: treatment of peptic ulcer disease and change in serum aluminium
concentration. Hepatogastroenterology. 1995 Jul;42(3):240-5. PubMed PMID:
7590572.
157: Keller A, Fuhr U, Sauter R, Steinijans VW, Staib AH. [Pharmacokinetics of a
theophylline effervescent tablet]. Pharmazie. 1995 May;50(5):356-8. German.
PubMed PMID: 7604069.
158: Henry P, Hiesse-Provost O, Dillenschneider A, Ganry H, Insuasty J. [Efficacy
and tolerance of an effervescent aspirin-metoclopramide combination in the
treatment of a migraine attack. Randomized double-blind study using a placebo].
Presse Med. 1995 Feb 4;24(5):254-8. French. PubMed PMID: 7899379.
159: Smout AJ, Jonkman JH, Peeters PA, De Bruin H. Effect of an evening dose of
regular and effervescent formulations of ranitidine or cimetidine on intragastric
pH in healthy volunteers. Aliment Pharmacol Ther. 1995 Feb;9(1):51-6. PubMed
PMID: 7766744.
160: Sun X, Zhang Z, Liu Z, Zhang W. [Quality standards of effervescent granules
for the treatment of cold pain]. Zhongguo Zhong Yao Za Zhi. 1995 Jan;20(1):26-30,
62. Chinese. PubMed PMID: 7626205.
161: Sharma NK, Kindelan JD, Hutchinson D, Lancaster L. A study to compare
ibuprofen effervescent granules with ibuprofen tablets in the treatment of acute
dental pain. Prim Dent Care. 1994 Sep;1(1):5-8. PubMed PMID: 8941780.
162: Brady AP. Use of effervescent agents in small bowel meal examination. Clin
Radiol. 1994 Jun;49(6):434-5. PubMed PMID: 8045075.
163: Löser C, Burlage M, Fölsch UR. [The effect of ranitidine and famotidine on
the intragastric pH profile of healthy subjects. Randomized cross-over trial with
ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg)
]. Arzneimittelforschung. 1994 May;44(5):626-9. German. PubMed PMID: 8024636.
164: Robbins MI, Shortsleeve MJ. Treatment of acute esophageal food impaction
with glucagon, an effervescent agent, and water. AJR Am J Roentgenol. 1994
Feb;162(2):325-8. PubMed PMID: 8310919.
165: Viel C. [The effervescent baths and mercurial fumigations of Guietand, a
Paris pharmacist]. Rev Hist Pharm (Paris). 1994;41(301):149-53. French. PubMed
PMID: 11640372.
166: Griffiths PD, Hufton AP, Martin DF. The use of effervescent agents in the
small bowel meal examination. Clin Radiol. 1993 Oct;48(4):275-7. PubMed PMID:
8243008.
167: Klein HM, Günther RW. Double contrast small bowel follow-through with an
acid-resistant effervescent agent. Invest Radiol. 1993 Jul;28(7):581-5. PubMed
PMID: 8344806.
168: Grossi L, Di Felice F, Marzio L. [Efficacy and tolerability of cisapride in
a new formula of 10 mg effervescent capsules for the treatment of functional
dyspepsia]. Clin Ter. 1993 Jun;142(6):521-7. Italian. PubMed PMID: 8354045.
169: Hakata T, Iijima M, Okabe T, Kimura S, Sato H, Watanabe Y, Matsumoto M.
Methods of evaluation of release of carbon dioxide from effervescent
suppositories. Chem Pharm Bull (Tokyo). 1993 Feb;41(2):346-50. PubMed PMID:
8500200.
170: Grossi L, Di Felice F, Marzio L. [A new granular effervescent 10-mg
formulation of cisapride in the treatment of gastroesophageal reflux]. Clin Ter.
1993 Feb;142(2):127-33. Italian. PubMed PMID: 8472526.
171: Hakata T, Iijima M, Kimura S, Sato H, Watanabe Y, Matsumoto M. Effects of
bases and additives on release of carbon dioxide from effervescent suppositories.
Chem Pharm Bull (Tokyo). 1993 Feb;41(2):351-6. PubMed PMID: 8388785.
172: Hartmann B, Schmieder G, Tetzloff W, Töberich H. [Bioequivalence and
bioavailability after single administration of effervescent ranitidine tablets].
Arzneimittelforschung. 1992 Aug;42(8):1020-2. German. PubMed PMID: 1418073.
173: Bloom RA, Craciun E, Lebensart PD, Levy P, Ziv JB. The ultrasound
appearances of intramural bowel gas: the bright ring appearance and the
effervescent bowel. A report of three cases. Br J Radiol. 1992 Jul;65(775):585-8.
PubMed PMID: 1515895.
174: Main J, Ward MK. Potentiation of aluminium absorption by effervescent
analgesic tablets in a haemodialysis patient. BMJ. 1992 Jun 27;304(6843):1686.
PubMed PMID: 1633526; PubMed Central PMCID: PMC1882349.
175: Ducrotté P, Weber J, Colin R, Denis P. Effect of an effervescent
citrate-cimetidine combination on intragastric pH in healthy subjects. A
randomized, placebo-controlled three-period cross-over design. Gastroenterol Clin
Biol. 1992;16(2):162-5. PubMed PMID: 1568544.
176: Andersen MP. Lack of bioequivalence between disulfiram formulations.
Exemplified by a tablet/effervescent tablet study. Acta Psychiatr Scand Suppl.
1992;369:31-5. PubMed PMID: 1471549.
177: Vlasblom V, Fellinger HW, Breumelhof R, Smout AJ. Effects of a new
effervescent cimetidine formulation on gastric acidity in healthy subjects. Neth
J Med. 1991 Apr;38(3-4):147-52. PubMed PMID: 1881502.
178: Hu YZ. [Observations in vivo on spermicidal effect of nonoxynol-9
contraceptive in forms of effervescent suppository and film]. Zhonghua Fu Chan Ke
Za Zhi. 1991 Mar;26(2):100-2, 125. Chinese. PubMed PMID: 1650310.
179: Ström M, Madsen S, Norlander B. Intragastric pH rise with effervescent
citrate-cimetidine. Lancet. 1991 Feb 16;337(8738):433. PubMed PMID: 1671456.
180: Raab FJ, Taylor CA, Bucher JA, Mann BL. Scanning electron microscopic
examination of ultrasonic and effervescent methods of surface contaminant removal
from complete dentures. J Prosthet Dent. 1991 Feb;65(2):255-8. PubMed PMID:
2051361.
181: Ekman M, Reizenstein P, Teigen SW, Rønneberg R. Comparative absorption of
calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and
chloride solution. Bone. 1991;12(2):93-7. PubMed PMID: 2064846.
182: Dorhout Mees EJ, Basçi A. Citric acid in calcium effervescent tablets may
favour aluminium intoxication. Nephron. 1991;59(2):322. PubMed PMID: 1956499.
183: Coleman RE, Dirix LY, Dodwell D, Tubiana-Hulin M, Body JJ, Becher R, White
GK, Rubens RD, Van Oosterom A, Howell A, et al. Phase I/II evaluation of
effervescent and enteric coated oral pamidronate for bone metastases. Eur J
Cancer. 1991;27(7):945-6. PubMed PMID: 1834134.
184: Katare OP, Vyas SP, Dixit VK. Effervescent granule based proliposomes of
ibuprofen. J Microencapsul. 1990 Oct-Dec;7(4):455-62. PubMed PMID: 2266470.
185: Mangez JF, Rachet B, Beaumont D, Moore N, Winckler C. [The effect of
effervescent cimetidine as premedication on gastric acidity during elective
cesareans]. Cah Anesthesiol. 1990 May-Jun;38(3):169-71. French. PubMed PMID:
2207826.
186: Ormezzano X, Francois TP, Viaud JY, Bukowski JG, Bourgeonneau MC, Cottron D,
Ganansia MF, Gregoire FM, Grinand MR, Wessel PE. Aspiration pneumonitis
prophylaxis in obstetric anaesthesia: comparison of effervescent
cimetidine-sodium citrate mixture and sodium citrate. Br J Anaesth. 1990
Apr;64(4):503-6. PubMed PMID: 2334627.
187: Kaszar-Seibert DJ, Korn WT, Bindman DJ, Shortsleeve MJ. Treatment of acute
esophageal food impaction with a combination of glucagon, effervescent agent, and
water. AJR Am J Roentgenol. 1990 Mar;154(3):533-4. PubMed PMID: 2106216.
188: Schmidt PC, Christin I. [Effervescent tablets–a nearly forgotten drug
form]. Pharmazie. 1990 Feb;45(2):89-101. Review. German. PubMed PMID: 2187207.
189: Ormezzano X, Ganansia MF, Arnould JF, Gregoire FM, Wessel PE, Bourgeonneau
MC, Bukowski JC, Grinand MR, Viaud JY, N’Guyen NQ. [Prevention of aspiration
pneumonia in obstetrical anesthesia with the effervescent combination of
cimetidine and sodium citrate]. Ann Fr Anesth Reanim. 1990;9(3):285-8. French.
PubMed PMID: 2372156.
190: Arvouet-Grand A, Lejeune B, Pourrat A. [Dietetic use of red sugarbeet
pigment–effervescent tablets]. Pharm Acta Helv. 1990;65(9-10):275-9. French.
PubMed PMID: 2236183.
191: Caliceti P, Sartore L, Schiavon O, Veronese FM. Evaluation of proteolytic
enzymes in effervescent tablets. Boll Chim Farm. 1989 Sep;128(9):267-70. PubMed
PMID: 2699717.
192: Kaltwasser JP, Schwarz-van de Sand W. [Oral iron therapy. Bioavailability
and therapeutic effectiveness of ferrous iron in effervescent tablets in
posthemorrhagic iron deficiency anemia]. Dtsch Med Wochenschr. 1989 Aug
4;114(31-32):1188-95. German. PubMed PMID: 2666080.
193: Dévay A, Kovács P, Rácz I. [Formulation of effervescent tablets containing
acetylsalicylic acid. III. Investigation of the stability of the active
principles of tablets]. Acta Pharm Hung. 1989 Jan;59(1):11-5. Hungarian. PubMed
PMID: 2711837.
194: Huber J. [Clinical experiences with iron-folic acid substitution in
pregnancy in the form of an effervescent tablet]. Wien Med Wochenschr. 1988 Nov
30;138(22):574-7. German. PubMed PMID: 3213066.
195: Tokola RA. The effect of metoclopramide and prochlorperazine on the
absorption of effervescent paracetamol in migraine. Cephalalgia. 1988
Sep;8(3):139-47. PubMed PMID: 3197094.
196: Lim JH. The effervescent gallbladder. AJR Am J Roentgenol. 1988
Sep;151(3):612. PubMed PMID: 3044044.
197: Dévay A, Uderszky J, Rácz I. [Formulation of effervescent tablets containing
acetylsalicylic acid. I. Investigation of granulation parameters]. Acta Pharm
Hung. 1988 May;58(3):97-100. Hungarian. PubMed PMID: 3245450.
198: Dévay A, Kovács P, Rác Z. [Formulation of effervescent tablets containing
acetylsalicylic acid. II. Investigation of parameters of effervescent tablets].
Acta Pharm Hung. 1988 May;58(3):101-3. Hungarian. PubMed PMID: 2854354.
199: Reiff RL, White CL, Overman P, ElAttar T, Platt RD. Aspirin, buffered
aspirin, and effervescent buffer rinses in reducing gingival inflammation in
patients with gingivitis and early periodontitis. Quintessence Int. 1988
Apr;19(4):287-90. PubMed PMID: 3269579.
200: Fahr F, Kala H, Fries G, Helbig G. [Improvement of the solubility of problem
drugs. 18. Iomeglamic acid-PVA effervescent powder]. Pharmazie. 1988
Mar;43(3):217. German. PubMed PMID: 3380871.
201: Nemcek AA Jr, Gore RM, Vogelzang RL, Grant M. The effervescent gallbladder:
a sonographic sign of emphysematous cholecystitis. AJR Am J Roentgenol. 1988
Mar;150(3):575-7. PubMed PMID: 3277349.
202: Linkosalo E, Markkanen S, Alakuijala P, Seppä L. Effects of some commercial
health beverages, effervescent vitamin C preparations and berries on human dental
enamel. Proc Finn Dent Soc. 1988;84(1):31-8. PubMed PMID: 3362850.
203: Nyström E, Gustafsson I, Quiding H. The pain intensity at analgesic intake,
and the efficacy of diflunisal in single doses and effervescent acetaminophen in
single and repeated doses. Pharmacotherapy. 1988;8(3):201-9. PubMed PMID:
3050906.
204: ElAttar TM, Lin HS, Platt RD. Effect of effervescent buffered aspirin on
prostaglandin synthesis by human gingival fibroblasts. Prostaglandins Leukot Med.
1987 Oct;29(2-3):237-47. PubMed PMID: 2829238.
205: Joachim J, Kalantzis G, Delonca H, Sabatier R, Abramovici B, Lheritier J,
Molard F. [Effervescent aspartame tablets. II. The effect of granulometry and
temperature on effervescence time and the kinetics and rate of carbon dioxide
liberation]. J Pharm Belg. 1987 Sep-Oct;42(5):303-14. French. PubMed PMID:
3123639.
206: Pochaczevsky R. Double-contrast examination of the colon with carbon
dioxide: the use of effervescent powder. AJR Am J Roentgenol. 1987
Sep;149(3):502-4. PubMed PMID: 3113194.
207: Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent
zinc acetate lozenges to alter the course of upper respiratory tract infections
in Australian adults. Antimicrob Agents Chemother. 1987 Aug;31(8):1263-5. PubMed
PMID: 3307620; PubMed Central PMCID: PMC174915.
208: Coates D. Relative stability of sodium hypochlorite liquids and sodium
dichloroisocyanurate effervescent disinfectant tablets. J Hosp Infect. 1987
Jul;10(1):96-7. PubMed PMID: 2888821.
209: Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of
tension headache. A double-blind, placebo controlled study. Headache. 1987
Feb;27(2):90-5. PubMed PMID: 3553071.
210: Silver B, Sundholm EG. Solid-state esterification of codeine phosphate by
the acid constituent of effervescent tablets. J Pharm Sci. 1987 Jan;76(1):53-5.
PubMed PMID: 3585724.
211: Joachim J, Kalantzis G, Delonca H, Abramovici B, Lheritier J, Molard F.
[Effervescent aspartame tablets: influence of granulometry on the stress exerted
at the level of compression]. J Pharm Belg. 1987 Jan-Feb;42(1):17-28. French.
PubMed PMID: 3585684.
212: Joachim J, Kalantzis G, Joachim G, Delonca H, Maury L, Rambaud J.
[Sweeteners in effervescent forms: pharmaceutical and physical chemistry]. Pharm
Acta Helv. 1987;62(9):262-8. French. PubMed PMID: 3423095.
213: Meurman JH, Murtomaa H. Effect of effervescent vitamin C preparations on
bovine teeth and on some clinical and salivary parameters in man. Scand J Dent
Res. 1986 Dec;94(6):491-9. PubMed PMID: 3468598.
214: Joachim J, Kalantzis G, Jacob M, Mention J, Maury L, Rambaud J. [Technology
of effervescent granules. Physico-chemical study]. J Pharm Belg. 1986
Jul-Aug;41(4):197-208. French. PubMed PMID: 3783403.
215: Cameron AE, Power I, Hart AM. In vitro buffering capacity of Alka Seltzer
Effervescent. Anaesthesia. 1986 Jul;41(7):776-7. PubMed PMID: 3752455.
216: Sendall FE, Staniforth JN. A study of powder adhesion to metal surfaces
during compression of effervescent pharmaceutical tablets. J Pharm Pharmacol.
1986 Jul;38(7):489-93. PubMed PMID: 2875146.
217: Murrell GC, Rosen M. In vitro buffering capacity of Alka Seltzer
Effervescent. A comparison with magnesium trisilicate mixture B.P. and sodium
citrate 0.3 M. Anaesthesia. 1986 Feb;41(2):138-42. PubMed PMID: 3006533.
218: Wahl RL. Gastric xenon trapping mimicking COPD: recognition using an
effervescent agent. Eur J Nucl Med. 1986;12(3):155-7. PubMed PMID: 3758105.
219: Moriyasu F, Ban N, Nakamura T, Nishida O, Soh Y, Miura K, Sakai M, Takeda Y,
Miyake T, Uchino H. [Contrast effects of glucagon and effervescent granules on
gastrointestinal MRI (magnetic resonance imaging)]. Nihon Shokakibyo Gakkai
Zasshi. 1986 Jan;83(1):40-6. Japanese. PubMed PMID: 3084835.
220: Heir RS, Allsup VE. Metabolic alkalosis induced by effervescent
preparations. Lancet. 1985 Nov 23;2(8465):1182-3. PubMed PMID: 2865632.
221: Agha FP, Trenkner SW, Woolsey EJ, Hayes D. Comparison of two effervescent
agents for double-contrast upper gastrointestinal tract radiography. Radiology.
1985 Nov;157(2):533-4. PubMed PMID: 4048464.
222: Joachim J, Kalantzis G, Cordoba J, Joachim G, Delonca H. [Application of new
technology for effervescent tablets to different active principles]. J Pharm
Belg. 1985 Jul-Aug;40(4):229-36. French. PubMed PMID: 4067808.
223: Dévay A, Uderszky J, Tanay J, Nyitrai T, Sátori E, Rácz I. [Preclinical and
clinical pharmacokinetic study of orally administered effervescent
acetylsalicylic acid tablets]. Acta Pharm Hung. 1985 May;55(3):114-8. Hungarian.
PubMed PMID: 4036626.
224: Mohammed SH. Andrew’s liver salt as an effervescent in upper
gastrointestinal radiography. Gastrointest Radiol. 1985;10(4):336-8. PubMed PMID:
4054498.
225: Nishimura K, Sasahara K, Arai M, Nitanai T, Ikegami Y, Morioka T, Nakajima
E. Dosage form design for improvement of bioavailability of levodopa VI:
formulation of effervescent enteric-coated tablets. J Pharm Sci. 1984
Jul;73(7):942-6. PubMed PMID: 6088756.
226: Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin
(Migravess) versus effervescent aspirin or placebo for migraine attacks: a
double-blind study. Cephalalgia. 1984 Jun;4(2):107-11. PubMed PMID: 6375873.
227: Chen CT, Toung TJ, Haupt HM, Hutchins GM, Cameron JL. Evaluation of the
efficacy of Alka-Seltzer Effervescent in gastric acid neutralization. Anesth
Analg. 1984 Mar;63(3):325-9. PubMed PMID: 6703349.
228: Fraser GM, Preston PG. The small bowel barium follow-through enhanced with
an oral effervescent agent. Clin Radiol. 1983 Nov;34(6):673-9. PubMed PMID:
6424999.
229: Joachim J, Cordoba J, Joachim G, Delonca H. [A standard effervescent couple:
demonstration of a method for humid granulation and control of CO2 liberation]. J
Pharm Belg. 1983 Sep-Oct;38(5):251-7. French. PubMed PMID: 6422027.
230: Garnier R, Riboulet-Delmas G, Efthymiou ML. [Acute poisoning by a buffered
effervescent aspirin with vitamin C. Retrospective study of data from the Poison
Control Center of Paris 1974-1981]. Sem Hop. 1983 Apr 28;59(17):1313-6. French.
PubMed PMID: 6306811.
231: Ala-Hurula V. Bioavailability and antimigraine efficacy of effervescent
ergotamine. Headache. 1982 Jul;22(4):167-70. PubMed PMID: 6809690.
232: Ross-Lee LM, Elms MJ, Cham BE, Bochner F, Bunce IH, Eadie MJ. Plasma levels
of aspirin following effervescent and enteric coated tablets, and their effect on
platelet function. Eur J Clin Pharmacol. 1982;23(6):545-51. PubMed PMID: 7160424.
233: Armandou JP, Mattha AG. Establishment of a geographical and chronological
map for relative humidity (R.H.) in an effervescent tablets manufacturing and
storage building. Pharm Acta Helv. 1982;57(10-11):287-9. PubMed PMID: 7146031.
234: Anderson NR, Banker GS, Peck GE. Quantitative evaluation of pharmaceutical
effervescent systems II: Stability monitoring by reactivity and porosity
measurements. J Pharm Sci. 1982 Jan;71(1):7-13. PubMed PMID: 7057384.
235: Anderson NR, Banker GS, Peck GE. Quantitative evaluation of pharmaceutical
effervescent systems I: Design of testing apparatus. J Pharm Sci. 1982
Jan;71(1):3-6. PubMed PMID: 6276529.
236: El-Banna HM, Minina SA. The construction and uses of factorial designs in
the preparation of solid dosage forms. Part 1: Effervescent acetylsalicylic acid
tablets. Pharmazie. 1981 Jun;36(6):417-20. PubMed PMID: 7279987.
237: Blowers AJ, Cameron EG, Lawrence ER. Effervescent ergotamine tartrate
(Effergot) in the treatment of the acute migraine attack. Br J Clin Pract. 1981
May;35(5):188-90. PubMed PMID: 6794589.
238: Koehler RE, Weyman PJ, Stanley RJ, Lee JK, Balfe DM. Evaluation of three
effervescent agents for double-contrast upper gastrointestinal radiography.
Gastrointest Radiol. 1981;6(2):111-4. PubMed PMID: 7250624.
239: Helliwell M, Berry D. Theophylline absorption by effervescent activated
charcoal (Medicoal). J Int Med Res. 1981;9(3):222-5. PubMed PMID: 7238997.
240: Virkkunen P, Kreula J. Effervescent agents in the double contrast
examination of the stomach. Acta Radiol Diagn (Stockh). 1981;22(3A):261-5. PubMed
PMID: 6797260.
241: Van de Voort PL. Effervescent granules for the barium meal. Br J Radiol.
1980 Jun;53(630):608. PubMed PMID: 7426880.
242: Shannon IL. Evaluation of a 0.1% SnF2 mouth rinse prepared from an
effervescent tablet. J Pedod. 1980 Fall;5(1):29-39. PubMed PMID: 6938663.
243: Sena FJ, Piechocki JT, Li KL. Stability-indicating assay of acetaminophen in
an effervescent tablet by ion-pair high-performance liquid chromatography. J
Pharm Sci. 1979 Nov;68(11):1465-6. PubMed PMID: 512905.
244: Masters WH, Johnson VE, Kolodny RC, Tullman GD. In vivo evaluation of an
effervescent intravaginal contraceptive insert by simulated coital activity.
Fertil Steril. 1979 Aug;32(2):161-5. PubMed PMID: 572784.
245: de Lacey GJ, Wignall BK, Bray C. Effervescent granules for the barium meal.
Br J Radiol. 1979 May;52(617):405-8. PubMed PMID: 444838.
246: Orton D, Treharne Jones R, Kaspi T, Richardson R. Plasma salicylate levels
after soluble and effervescent aspirin. Br J Clin Pharmacol. 1979 Apr;7(4):410-2.
PubMed PMID: 444362; PubMed Central PMCID: PMC1429652.
247: Medicoal (effervescent activated charcoal) in the treatment of acute
poisoning. Drug Ther Bull. 1979 Jan 19;17(2):7-8. PubMed PMID: 759130.
248: Spitz HD. Determination of water in aluminum chlorohydrate and effervescent
tablets by Karl Fischer Analysis. J Pharm Sci. 1979 Jan;68(1):122-3. PubMed PMID:
758451.
249: Mertz DP. [The uric acid-lowering action of benzbromarone effervescent
granules and allopurinol. Comparative studies (author’s transl)]. MMW Munch Med
Wochenschr. 1978 Oct 20;120(42):1387-90. German. PubMed PMID: 101792.
250: Mugnier A. [Effervescent Paracetamol in odonto-stomatology for children].
Rev Odontostomatol (Paris). 1978 Jul-Aug;7(4):301-6. French. PubMed PMID: 281732.
251: Faguet JP, Duchĕne D, Puisieux F. [Tablets. 18. Influence of the method of
granulation and climatic conditions on the shelf life of effervescent sodium-free
acetylsalicylic acid tablets]. Pharm Acta Helv. 1978;53(7):197-204. French.
PubMed PMID: 733821.
252: Wainscott G, Kaspi T, Volans GN. The influence of thiethylperazine on the
absorption of effervescent aspirin in migraine. Br J Clin Pharmacol. 1976
Dec;3(6):1015-21. PubMed PMID: 22216523; PubMed Central PMCID: PMC1428962.
253: Broda H. [Bitter salt spring water from the Inowrocław Spa in the form of
effervescent tablets]. Pol Tyg Lek. 1976 Jul 12;31(28):1195-6. Polish. PubMed
PMID: 959032.
254: Johnson F, Gibbons DR. Microprocessors in health care: panacea or more
effervescent technology? Biomed Eng. 1976 Apr;11(4):132-6. PubMed PMID: 1276336.
255: Picha E. [Iron treatment by effervescent tablets (author’s transl)].
Geburtshilfe Frauenheilkd. 1975 Oct;35(10):792-5. German. PubMed PMID: 1102383.
256: Fascetti Testi P, Rosini S, Silvestri S. [Study of absorption, in man, of an
effervescent preparation N-acetyl-p-aminophenol (paracetamol)]. Farmaco Prat.
1975 Sep;30(9):437-44. Italian. PubMed PMID: 1183577.
257: Kovács I. [Procedure for the preparation of effervescent vaginal tablets for
veterinary use]. Acta Pharm Hung. 1975 Jul;45(4):160-6. Hungarian. PubMed PMID:
807083.
258: Villiaumey J, Faguet JP, Puisieux F, Mollet M, Chanzy MO. [Effervescent
aspirin without sodium. Preliminary clinical study]. Therapie. 1975
May-Jun;30(3):451-4. French. PubMed PMID: 1224366.
259: Volans GN. The effect of metoclopramide on the absorption of effervescent
aspirin in migraine. Br J Clin Pharmacol. 1975 Feb;2(1):57-63. PubMed PMID:
791318; PubMed Central PMCID: PMC1402484.
260: Faguet JP, Spingler E, Duchène D, Puisieux F. [Tablets. XVI. The influence
of humidity and temperature on the preservation of effervescent tablets]. Pharm
Acta Helv. 1975;50(9):251-61. French. PubMed PMID: 1178722.
261: Volans GN. Absorption of effervescent aspirin during migraine. Br Med J.
1974 Nov 2;4(5939):265-8. PubMed PMID: 4425854; PubMed Central PMCID: PMC1612218.
262: Hedges A, Kaye CM, Maclay WP, Turner P. A comparison of the absorption of
effervescent preparations of paracetamol and penicillin V
(phenoxymethylpenicillin) with solid dose forms of these drugs. J Clin Pharmacol.
1974 Jul;14(7):363-8. PubMed PMID: 4210848.
263: Volans GN. Effects of food and exercise on the absorption of effervescent
aspirin. Br J Clin Pharmacol. 1974 Apr;1(2):137-41. PubMed PMID: 22454900; PubMed
Central PMCID: PMC1402447.
264: Mathieu L. [Clinical trial in odontostomatology of a combination of
paracetamol and ascorbic acid in effervescent form]. Rev Odontostomatol (Paris).
1974 Mar-Apr;3(2):169-76. French. PubMed PMID: 4619215.
265: Aiache JM. [Effervescent tablets]. Pharm Acta Helv. 1974;49(5-6):169-77.
French. PubMed PMID: 4445187.
266: Gädeke R, Sander C, Schmidt P, Steinitz H. [Scope of usability, tolerance
and blood levels of potassium phenoxymethyl penicillin effervescent tablets in
children]. Med Klin. 1972 Sep 15;67(37):1173-5. German. PubMed PMID: 4628131.
267: Ali SL. [Citric acid determination in calcium-vitamin C effervescent
tablets]. Arch Pharm (Weinheim). 1972 Mar;305(3):219-21. German. PubMed PMID:
5048249.
268: [Kalk-xitix. Effervescent tablets for the prevention and treatment of
vitamin C and calcium deficiency symptoms]. Med Monatsschr. 1971 Oct;25(10):482.
German. PubMed PMID: 5122451.
269: Mielck W. [Marfluan–an effervescent dentifrice salt with myrrh]. Dent
Dienst. 1970 Nov;22(11):21. German. PubMed PMID: 5277612.
270: Lindberg NO. Preparation of effervescent tablets containing nicotinic acid
and sodium bicarbonate. Acta Pharm Suec. 1970 Feb;7(1):23-8. PubMed PMID:
5450401.
271: Murray RB. New approach to the fusion method for preparing granular
effervescent products. J Pharm Sci. 1968 Oct;57(10):1776-9. PubMed PMID: 5684752.
272: Neri G. [Vaginal effervescent suppositories with a fatty base]. Boll Chim
Farm. 1967 Nov;106(11):783-6. Italian. PubMed PMID: 5629419.
273: MATES J, SADILEK L. [THE SPECIFIC EFFECTS OF EFFERVESCENT CARBON DIOXIDE
BATH]. Fysiatr Revmatol Vestn. 1965 Jun;43:149-56. Czech. PubMed PMID: 14331077.
274: Amacker P. [Study on the preparation and determination of effervescent
tablets with essences (for inhalations and gargles)]. Pharm Acta Helv. 1965
Jun;40(6):345-60. French. PubMed PMID: 5867997.
275: Ducas J, Vert P, Steffann J, Thiriet M. [Use in pediatrics of an
effervescent derivative of prednisolone]. Ann Med Nancy. 1965 May;4:519-26.
French. PubMed PMID: 5830248.
276: García Otero V, García Fernández JL, Pescador del Hoyo L. [Results obtained
with effervescent potassium in the treatment of definite myocardial changes]. Rev
Esp Cardiol. 1965 Apr;18(2):238-50. Spanish. PubMed PMID: 5834379.
277: WEIL L, MATES J. [CONCENTRATION OF CARBON DIOXIDE IN INSPIRED AIR FOLLOWING
EFFERVESCENT BATHS]. Fysiatr Revmatol Vestn. 1965 Feb;43:12-5. Czech. PubMed
PMID: 14276722.
278: COLETTA V, KENNON L. NEW PREPARATIVE TECHNIQUE FOR EFFERVESCENT PRODUCTS. J
Pharm Sci. 1964 Dec;53:1524-5. PubMed PMID: 14255137.
279: RUBIN IC. A simplified light-weight apparatus for kymographic uterotubal
insufflation, with an effervescent tablet as source of carbon dioxide. J Am Med
Assoc. 1955 Nov 19;159(12):1190-2. PubMed PMID: 13263166.
280: EFFERVESCENT baths. Br J Phys Med. 1953 May;16(5):102-3. PubMed PMID:
13042049.
281: LOLLI G, SMITH R. Effervescent mixtures as adjuvants to the rapid absorption
of ingested drugs. N Engl J Med. 1946 Jul 18;235:80-4. PubMed PMID: 20991530.
282: JONES GK. Effervescent granular preparations. Manuf Chem Aerosol News. 1946
May;17:190-2. PubMed PMID: 20985315.

 

 
1: Stocchi F, Vacca L, Grassini P, Pawsey S, Whale H, Marconi S, Torti M. L-Dopa
Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus
Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised
Study. Parkinsons Dis. 2015;2015:369465. doi: 10.1155/2015/369465. Epub 2015 Jun
10. PubMed PMID: 26171276; PubMed Central PMCID: PMC4478358.
2: Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B,
Chung LY, Noordin MI. Formulation and in vitro, in vivo evaluation of
effervescent floating sustained-release imatinib mesylate tablet. PLoS One. 2015
Jun 2;10(6):e0126874. doi: 10.1371/journal.pone.0126874. eCollection 2015. PubMed
PMID: 26035710; PubMed Central PMCID: PMC4452730.
3: Qi X, Chen H, Rui Y, Yang F, Ma N, Wu Z. Floating tablets for controlled
release of ofloxacin via compression coating of hydroxypropyl cellulose combined
with effervescent agent. Int J Pharm. 2015 Jul 15;489(1-2):210-7. doi:
10.1016/j.ijpharm.2015.05.007. Epub 2015 May 5. PubMed PMID: 25956047.
4: Meka VS, Pillai S, Dharmalingham SR, Sheshala R, Gorajana A. Preparation and
in vitro characterization of a non-effervescent floating drug delivery system for
poorly soluble drug, glipizide. Acta Pol Pharm. 2015 Jan-Feb;72(1):193-204.
PubMed PMID: 25850215.
5: Rahim SA, Carter PA, Elkordy AA. Design and evaluation of effervescent
floating tablets based on hydroxyethyl cellulose and sodium alginate using
pentoxifylline as a model drug. Drug Des Devel Ther. 2015 Mar 31;9:1843-57. doi:
10.2147/DDDT.S78717. eCollection 2015. PubMed PMID: 25848220; PubMed Central
PMCID: PMC4386796.
6: Srikanth Meka V, Wee Liang VA, Dharmalingham SR, Sheshala R, Gorajana A.
Preparation and in vitro characterization of non-effervescent floating drug
delivery system of poorly soluble drug, carvedilol phosphate. Acta Pharm. 2014
Dec;64(4):485-94. doi: 10.2478/acph-2014-0038. PubMed PMID: 25531788.
7: Ye LH, Cao W, Hu SS, Da JH, Dai HB, Cao J, Xu JJ, Pang XQ.
Effervescent-salt-assisted dispersive micro-solid-phase extraction using
mesoporous hybrid materials coupled with ultra-performance liquid chromatography
for the determination of trace-level compounds in complicated plant preparations.
Anal Bioanal Chem. 2015 Feb;407(6):1763-73. doi: 10.1007/s00216-014-8396-1. Epub
2014 Dec 20. PubMed PMID: 25527130.
8: Ringe KI, Meyer S, Ringe BP, Winkler M, Wacker F, Raatschen HJ. Value of oral
effervescent powder administration for multidetector CT evaluation of esophageal
cancer. Eur J Radiol. 2015 Feb;84(2):215-20. doi: 10.1016/j.ejrad.2014.11.008.
Epub 2014 Nov 18. PubMed PMID: 25497235.
9: Khan A, Iqbal Z, Rehman Z, Nasir F, Khan A, Ismail M, Roohullah, Mohammad A.
Application of SeDeM Expert system in formulation development of effervescent
tablets by direct compression. Saudi Pharm J. 2014 Nov;22(5):433-44. doi:
10.1016/j.jsps.2013.07.002. Epub 2013 Aug 8. PubMed PMID: 25473332; PubMed
Central PMCID: PMC4246396.
10: Cooper G, Foster J, Galbraith L, Jain S, Neukermans A, Ormond B. Preliminary
results for salt aerosol production intended for marine cloud brightening, using
effervescent spray atomization. Philos Trans A Math Phys Eng Sci. 2014 Dec
28;372(2031). pii: 20140055. doi: 10.1098/rsta.2014.0055. PubMed PMID: 25404673;
PubMed Central PMCID: PMC4240953.
11: Aslani A, Sharifian T. Formulation, characterization and physicochemical
evaluation of amoxicillin effervescent tablets. Adv Biomed Res. 2014 Oct
20;3:209. doi: 10.4103/2277-9175.143252. eCollection 2014. PubMed PMID: 25371866;
PubMed Central PMCID: PMC4219208.
12: Hu Y, Ju SH, Zhang YJ, Xiong M, Xu SJ, Ma YT, Zhong ZD. [Effect of Tongluo
Xingnao effervescent tablets on learning and memory dysfunction in rats with
chronic cerebral ischemia]. Zhongguo Zhong Yao Za Zhi. 2014 May;39(10):1908-12.
Chinese. PubMed PMID: 25282904.
13: Jiang W, Chen X, Liu F, You X, Xue J. Effervescence-assisted dispersive
liquid-liquid microextraction using a solid effervescent agent as a novel
dispersion technique for the analysis of fungicides in apple juice. J Sep Sci.
2014 Nov;37(21):3157-63. doi: 10.1002/jssc.201400695. Epub 2014 Sep 22. PubMed
PMID: 25136817.
14: Nazir SR, Ambreen G, Irfan HM, Bashir S, Rauf A. Development and formulation
of metformin (Antidiabetic) effervescent Granules: to increase patient compliance
and its stability study. Pak J Pharm Sci. 2014 Jul;27(4):763-6. PubMed PMID:
25015437.
15: Invernizzi M, Cisari C, Carda S. The potential impact of new effervescent
alendronate formulation on compliance and persistence in osteoporosis treatment.
Aging Clin Exp Res. 2015 Apr;27(2):107-13. doi: 10.1007/s40520-014-0256-5. Epub
2014 Jul 5. PubMed PMID: 24996788.
16: Kriangkrai W, Puttipipatkhachorn S, Sriamornsak P, Pongjanyakul T,
Sungthongjeen S. Impact of anti-tacking agents on properties of gas-entrapped
membrane and effervescent floating tablets. AAPS PharmSciTech. 2014
Dec;15(6):1357-69. doi: 10.1208/s12249-014-0161-4. Epub 2014 Jun 14. PubMed PMID:
24927669; PubMed Central PMCID: PMC4245443.
17: Szałek E, Karbownik A, Murawa D, Połom K, Urbaniak B, Grabowski T, Wolc A,
Więckiewicz A, Grześkowiak E, Kokot ZJ, Murawa P, Burchardt P, Cieśla S. The
pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol
fixed-dose combination tablet in patients after total gastric resection.
Pharmacol Rep. 2014 Feb;66(1):159-64. doi: 10.1016/j.pharep.2013.06.010. Epub
2014 Feb 5. PubMed PMID: 24905322.
18: Jaipal A, Pandey MM, Charde SY, Sadhu N, Srinivas A, Prasad RG. Controlled
release effervescent buccal discs of buspirone hydrochloride: in vitro and in
vivo evaluation studies. Drug Deliv. 2014 Jun 3:1-7. [Epub ahead of print] PubMed
PMID: 24892624.
19: Mohammed KA, Ibrahim HK, Ghorab MM. Effervescent tablet formulation for
enhanced patient compliance and the therapeutic effect of risperidone. Drug
Deliv. 2014 May 15:1-10. [Epub ahead of print] PubMed PMID: 24833273.
20: Sánchez-Jurado R, Ferrer-Rebolleda J, Cózar-Santiago Mdel P, Aguilar-Barrios
JE, Devis-Saiz M, Sanz-Llorens R. Use of an oral effervescent agent in the
diagnostic of gastric carcinoma with 18F-FDG PET/CT. Rev Esp Enferm Dig. 2014
Jan;106(1):68-9. PubMed PMID: 24689724.
21: He LY, Zhang GL, Yan SY, Liu Y, Zhao CS, Wang XL, Li Y, Mi YQ, Liu YM, Li CP,
Kou YH, Li Y, Chang K, Meng XL, Sun XJ, Zhao T, Li J, Wang YY, Liu BY. A
double-blind comparative study of Chinese herbal medicine Jinlianqingre
Effervescent Tablets in combination with conventional therapy for the treatment
of uncomplicated hand, foot, and mouth disease. Eur J Clin Microbiol Infect Dis.
2014 Aug;33(8):1429-37. doi: 10.1007/s10096-014-2085-z. Epub 2014 Mar 19. PubMed
PMID: 24643639.
22: Paulson RJ, Collins MG, Yankov VI. Progesterone pharmacokinetics and
pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized
progesterone vaginal insert. J Clin Endocrinol Metab. 2014 Nov;99(11):4241-9.
doi: 10.1210/jc.2013-3937. Epub 2014 Feb 25. PubMed PMID: 24606090.
23: Acharya S, Patra S, Pani NR. Optimization of HPMC and carbopol concentrations
in non-effervescent floating tablet through factorial design. Carbohydr Polym.
2014 Feb 15;102:360-8. doi: 10.1016/j.carbpol.2013.11.060. Epub 2013 Dec 6.
PubMed PMID: 24507292.
24: Zhang YJ, Dai Y, Hu Y, Ma YT, Xu SJ, Wang YY. [Effect of tongluo xingnao
effervescent tablet on learning and memory of AD rats and expression of
insulin-degrading enzyme in hippocampus]. Zhongguo Zhong Yao Za Zhi. 2013
Sep;38(17):2863-7. Chinese. PubMed PMID: 24380312.
25: Miao RM, Sun XF, Zhang YY, Wu W, Fang ZH, Zhao R, Zhao DK, Qian GL, Ji J.
[Clinical efficacy of tetrandrine combined with acetylcysteine effervescent
tablets in treatment of silicosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za
Zhi. 2013 Nov;31(11):857-8. Chinese. PubMed PMID: 24370303.
26: Cansu A, Ahmetoglu A, Kul S, Yukunc G, Fidan S, Arslan M, Topbas M.
Diagnostic performance of using effervescent powder for detection and grading of
esophageal varices by multi-detector computed tomography. Eur J Radiol. 2014
Mar;83(3):497-502. doi: 10.1016/j.ejrad.2013.11.014. Epub 2013 Dec 4. PubMed
PMID: 24355657.
27: Aslani A, Jahangiri H. Formulation, characterization and physicochemical
evaluation of ranitidine effervescent tablets. Adv Pharm Bull. 2013;3(2):315-22.
doi: 10.5681/apb.2013.051. Epub 2013 Aug 20. PubMed PMID: 24312854; PubMed
Central PMCID: PMC3848210.
28: Aslani A, Fattahi F. Formulation, characterization and physicochemical
evaluation of potassium citrate effervescent tablets. Adv Pharm Bull.
2013;3(1):217-25. doi: 10.5681/apb.2013.036. Epub 2013 Feb 7. PubMed PMID:
24312839; PubMed Central PMCID: PMC3846033.
29: George J, Majeed W, Mackenzie IS, Macdonald TM, Wei L. Association between
cardiovascular events and sodium-containing effervescent, dispersible, and
soluble drugs: nested case-control study. BMJ. 2013 Nov 26;347:f6954. doi:
10.1136/bmj.f6954. PubMed PMID: 24284017; PubMed Central PMCID: PMC3898660.
30: Guo SS, Gao YJ, Tian XC, Jin YH, Liu FZ, Cui XL. [Effect of xuebijing oral
effervescent tablet on endotoxin induced fever and disseminated intravascular
coagulation rabbit model]. Yao Xue Xue Bao. 2013 Aug;48(8):1241-6. Chinese.
PubMed PMID: 24187830.
31: Wei Y, Xue Z, Ye Y, Huang Y, Zhao L. Paclitaxel targeting to lungs by way of
liposomes prepared by the effervescent dispersion technique. Arch Pharm Res. 2014
Jun;37(6):728-37. doi: 10.1007/s12272-013-0181-8. Epub 2013 Jun 18. PubMed PMID:
23775475.
32: Wabaidur SM, Alothman ZA, Khan MR. A rapid method for the simultaneous
determination of L-ascorbic acid and acetylsalicylic acid in aspirin C
effervescent tablet by ultra performance liquid chromatography-tandem mass
spectrometry. Spectrochim Acta A Mol Biomol Spectrosc. 2013 May;108:20-5. doi:
10.1016/j.saa.2013.01.070. Epub 2013 Feb 6. PubMed PMID: 23454710.
33: Figueroa CE, Adamson DH, Prud’homme RK. Effervescent redispersion of
lyophilized polymeric nanoparticles. Ther Deliv. 2013 Feb;4(2):177-90. doi:
10.4155/tde.12.138. PubMed PMID: 23343158.
34: Getyala A, Gangadharappa HV, Prasad MS, Reddy MP, Kumar TM. Formulation and
evaluation of non-effervescent floating tablets of losartan potassium. Curr Drug
Deliv. 2013 Oct;10(5):620-9. PubMed PMID: 23286884.
35: Niederhauser BD, Atwell TD, MacCarty RL, Bender CE. Gas-containing gallstones
as a cause of the “effervescent gallbladder” sign and pneumobilia. J Clin
Ultrasound. 2013 Nov-Dec;41 Suppl 1:50-3. doi: 10.1002/jcu.22020. Epub 2012 Dec
1. PubMed PMID: 23203480.
36: In brief: effervescent alendronate. Med Lett Drugs Ther. 2012 Oct
15;54(1401):84. PubMed PMID: 23059422.
37: Yao XQ, Zhang YH, Sun CH. [Protective effects of Xuebijing effervescent
tablet on vital organs in rats with toxic injury induced by endotoxin]. Zhongguo
Wei Zhong Bing Ji Jiu Yi Xue. 2012 Jun;24(6):357-9. Chinese. PubMed PMID:
23019734.
38: Al-Hallak MH, Sarfraz MK, Azarmi S, Roa WH, Finlay WH, Rouleau C, Löbenberg
R. Distribution of effervescent inhalable nanoparticles after pulmonary delivery:
an in vivo study. Ther Deliv. 2012 Jun;3(6):725-34. PubMed PMID: 22838068.
39: Vötsch A, Beran E, Zirngast B, Mächler H. Re-sternotomy as an unwelcome
side-effect of unknown effervescent tablet intake? Interact Cardiovasc Thorac
Surg. 2012 Sep;15(3):558-9. doi: 10.1093/icvts/ivs183. Epub 2012 May 22. PubMed
PMID: 22617503; PubMed Central PMCID: PMC3422925.
40: Hodges LA, Connolly SM, Winter J, Schmidt T, Stevens HN, Hayward M, Wilson
CG. Modulation of gastric pH by a buffered soluble effervescent formulation: A
possible means of improving gastric tolerability of alendronate. Int J Pharm.
2012 Aug 1;432(1-2):57-62. doi: 10.1016/j.ijpharm.2012.04.073. Epub 2012 May 4.
PubMed PMID: 22564778.
41: Meka VS, Songa AS, Nali SR, Battu JR, Kolapalli VR. Design and in vitro
evaluation of effervescent gastric floating drug delivery systems of propanolol
HCl. Invest Clin. 2012 Mar;53(1):60-70. PubMed PMID: 22524109.
42: Sakhaee K, Pak C. Superior calcium bioavailability of effervescent potassium
calcium citrate over tablet formulation of calcium citrate after Roux-en-Y
gastric bypass. Surg Obes Relat Dis. 2013 Sep-Oct;9(5):743-8. doi:
10.1016/j.soard.2011.11.011. Epub 2011 Dec 3. PubMed PMID: 22222299.
43: Wening K, Laukamp EJ, Thommes M, Breitkreutz J. Individual oral therapy with
immediate release and effervescent formulations delivered by the solid dosage
pen. J Pers Med. 2012 Nov 6;2(4):217-31. doi: 10.3390/jpm2040217. PubMed PMID:
25562361; PubMed Central PMCID: PMC4251373.
44: Negi JS, Trivedi A, Khanduri P, Negi V, Kasliwal N. Effect of bioadhesion on
initial in vitro buoyancy of effervescent floating matrix tablets of
ciprofloxacin HCL. J Adv Pharm Technol Res. 2011 Apr;2(2):121-7. doi:
10.4103/2231-4040.82954. PubMed PMID: 22171304; PubMed Central PMCID: PMC3217692.
45: Yamada T, Inoue Y, Asano Y, Nippashi Y, Woodhams R, Matsunaga K, Tago M. Use
of an oral effervescent agent in the evaluation of gastric 67Ga uptake. Ann Nucl
Med. 2012 Feb;26(2):192-6. doi: 10.1007/s12149-011-0554-3. Epub 2011 Nov 15.
PubMed PMID: 22081275.
46: Zheng P, Meng LJ, Sun GP, Wang WZ. [Study on optimization of formulation of
Danggui Liuhuang effervescent granules]. Zhong Yao Cai. 2011 Mar;34(3):452-5.
Chinese. PubMed PMID: 21823466.
47: Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, Mohrbacher
R, Levitt M, Greinwald R, Shapira MY. Improvement in oral chronic
graft-versus-host disease with the administration of effervescent tablets of
topical budesonide-an open, randomized, multicenter study. Biol Blood Marrow
Transplant. 2012 Jan;18(1):134-40. doi: 10.1016/j.bbmt.2011.06.001. Epub 2011 Jun
12. PubMed PMID: 21703973.
48: Someshwar K, Chithaluru K, Ramarao T, Kumar KK. Formulation and evaluation of
effervescent floating tablets of tizanidine hydrochloride. Acta Pharm. 2011
Jun;61(2):217-26. doi: 10.2478/v10007-011-0015-5. PubMed PMID: 21684848.
49: Maximiano FP, Costa GH, de Sá Barreto LC, Bahia MT, Cunha-Filho MS.
Development of effervescent tablets containing benzonidazole complexed with
cyclodextrin. J Pharm Pharmacol. 2011 Jun;63(6):786-93. doi:
10.1111/j.2042-7158.2011.01284.x. Epub 2011 May 3. PubMed PMID: 21585376.
50: Bani-Jaber AK, Alkawareek MY, Al-Gousous JJ, Abu Helwa AY. Floating and
sustained-release characteristics of effervescent tablets prepared with a mixed
matrix of Eudragit L-100-55 and Eudragit E PO. Chem Pharm Bull (Tokyo).
2011;59(2):155-60. PubMed PMID: 21297292.
51: Shirsand SB, Suresh S, Jodhana LS, Swamy PV. Formulation design and
optimization of fast disintegrating Lorazepam tablets by effervescent method.
Indian J Pharm Sci. 2010 Jul;72(4):431-6. doi: 10.4103/0250-474X.73911. PubMed
PMID: 21218052; PubMed Central PMCID: PMC3013557.
52: Gande S, Rao Y. Sustained-release effervescent floating matrix tablets of
baclofen: development, optimization and in vitro-in vivo evaluation in healthy
human volunteers. Daru. 2011;19(3):202-9. PubMed PMID: 22615658; PubMed Central
PMCID: PMC3232112.
53: Liu YM, Liu Y, Lu C, Jia JY, Liu GY, Weng LP, Wang JY, Li GX, Wang W, Li SJ,
Yu C. Relative bioavailability of generic and branded acetylcysteine effervescent
tablets: A single-dose, open-label, randomized-sequence, two-period crossover
study in fasting healthy Chinese male volunteers. Clin Ther. 2010
Nov;32(12):2097-105. doi: 10.1016/j.clinthera.2010.11.001. PubMed PMID: 21118745.
54: Yeniocak S, Tatli O, Cansu A, Erturk E, Erol MM, Turedi S. Acute severe
respiratory distress secondary to misuse of an N-acetylcysteine effervescent
tablet. Am J Emerg Med. 2010 Sep;28(7):842.e5-6. doi: 10.1016/j.ajem.2009.11.013.
Epub 2010 Apr 2. PubMed PMID: 20837268.
55: Stocchi F, Zappia M, Dall’Armi V, Kulisevsky J, Lamberti P, Obeso JA;
Melevodopa Plus Carbidopa Study Group. Melevodopa/carbidopa effervescent
formulation in the treatment of motor fluctuations in advanced Parkinson’s
disease. Mov Disord. 2010 Sep 15;25(12):1881-7. doi: 10.1002/mds.23206. PubMed
PMID: 20669296.
56: de Andrade IM, Cruz PC, da Silva CH, de Souza RF, Paranhos Hde F, Candido RC,
Marin JM, de Souza-Gugelmin MC. Effervescent tablets and ultrasonic devices
against Candida and mutans streptococci in denture biofilm. Gerodontology. 2011
Dec;28(4):264-70. doi: 10.1111/j.1741-2358.2010.00378.x. Epub 2010 May 26. PubMed
PMID: 20518813.
57: Zhao L, Wei Y, Li W, Liu Y, Wang Y, Zhong X, Yu Y. Solid dispersion and
effervescent techniques used to prepare docetaxel liposomes for lung-targeted
delivery system: in vitro and in vivo evaluation. J Drug Target. 2011
Apr;19(3):171-8. doi: 10.3109/10611861003801859. Epub 2010 Apr 30. PubMed PMID:
20429774.
58: He Y, Xin H, Huang K, Zhang Y, Luo X. [Effect of alcohol concentration in
water extraction and alcohol precipitation on preparation of effervescent tablets
of Banlangen]. Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(3):288-92. Chinese. PubMed
PMID: 20422990.
59: Gauniya A, Das S, Mallick S, Basu SP. Comparative bioavailability studies of
citric acid and malonic acid based aspirin effervescent tablets. J Pharm
Bioallied Sci. 2010 Apr;2(2):118-20. doi: 10.4103/0975-7406.67015. PubMed PMID:
21814444; PubMed Central PMCID: PMC3147094.
60: Swamy PV, Divate SP, Shirsand SB, Rajendra P. Preparation and evaluation of
orodispersible tablets of pheniramine maleate by effervescent method. Indian J
Pharm Sci. 2009 Mar;71(2):151-4. doi: 10.4103/0250-474X.54284. PubMed PMID:
20336216; PubMed Central PMCID: PMC2839404.
61: Nagendrakumar D, Raju SA, Shirsand SB, Para MS, Rampure MV. Fast Dissolving
Tablets of Fexofenadine HCl by Effervescent Method. Indian J Pharm Sci. 2009
Mar;71(2):116-9. doi: 10.4103/0250-474X.54272. PubMed PMID: 20336204; PubMed
Central PMCID: PMC2839392.
62: Rajab M, Jouma M, Neubert RH, Dittgen M. Optimization of a metformin
effervescent floating tablet containing hydroxypropylmethylcellulose and stearic
acid. Pharmazie. 2010 Feb;65(2):97-101. PubMed PMID: 20225651.
63: Tadros MI. Controlled-release effervescent floating matrix tablets of
ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo
evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010
Feb;74(2):332-9. doi: 10.1016/j.ejpb.2009.11.010. Epub 2009 Nov 22. PubMed PMID:
19932750.
64: Fentanyl effervescent buccal tablets: new formulation. For cancer patients
with breakthrough pain: a second buccal formulation with minimal evaluation.
Prescrire Int. 2009 Oct;18(103):205. PubMed PMID: 19882786.
65: Ibrahim HK. A novel liquid effervescent floating delivery system for
sustained drug delivery. Drug Discov Ther. 2009 Aug;3(4):168-75. PubMed PMID:
22495603.
66: Xue L, Li Y, Guo D, Yin J, Liu Y, Hou S. [Study on preparation and release
mechanism of effervescent osmotic pump tablet of compound Danshen]. Zhongguo
Zhong Yao Za Zhi. 2009 Apr;34(7):848-51. Chinese. PubMed PMID: 19623978.
67: Ubeda A, Llopico J, Sanchez MT. Blood pressure reduction in hypertensive
patients after withdrawal of effervescent medication. Pharmacoepidemiol Drug Saf.
2009 May;18(5):417-9. doi: 10.1002/pds.1701. PubMed PMID: 19248080.
68: Pisani MX, Silva-Lovato CH, Malheiros-Segundo Ade L, Macedo AP, Paranhos HF.
Bond strength and degree of infiltration between acrylic resin denture liner
after immersion in effervescent denture cleanser. J Prosthodont. 2009
Feb;18(2):123-9. doi: 10.1111/j.1532-849X.2008.00380.x. Epub 2008 Oct 20. PubMed
PMID: 19178623.
69: Jacob S, Shirwaikar A, Nair A. Preparation and evaluation of
fast-disintegrating effervescent tablets of glibenclamide. Drug Dev Ind Pharm.
2009 Mar;35(3):321-8. doi: 10.1080/03639040802337021 . PubMed PMID: 18821151.
70: Azarmi S, Lobenberg R, Roa WH, Tai S, Finlay WH. Formulation and in vivo
evaluation of effervescent inhalable carrier particles for pulmonary delivery of
nanoparticles. Drug Dev Ind Pharm. 2008 Sep;34(9):943-7. doi:
10.1080/03639040802149079 . PubMed PMID: 18800255.
71: Luo XJ, Xin HL, Rao XY, Xiao ZQ, Gao LL, Sun TT, Guo QL. [Review of
effervescent technique in pharmaceutics research]. Zhongguo Zhong Yao Za Zhi.
2008 Apr;33(8):973-6. Review. Chinese. PubMed PMID: 18619362.
72: Jin GY, Park SH, Han YM. Usefulness of MDCT evaluation of the intraluminal
surface of esophageal masses using only effervescent powder without injection of
hypotonic agent. Abdom Imaging. 2009 Jul;34(4):424-9. doi:
10.1007/s00261-008-9398-2. PubMed PMID: 18493816.
73: Améndola R, Santos MC, Massa JM, Vazquez H, Smecuol E. Effects of a single
low dose of ranitidine and effervescent antacids on intragastric acidity in
healthy volunteers. Acta Gastroenterol Latinoam. 2007 Dec;37(4):231-7. PubMed
PMID: 18254261.
74: Freye E. A new transmucosal drug delivery system for patients with
breakthrough cancer pain: the fentanyl effervescent buccal tablet. J Pain Res.
2008 Dec 17;2:13-20. PubMed PMID: 21197291; PubMed Central PMCID: PMC3004632.
75: Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of
breakthrough pain in patients compared to immediate release morphine sulfate
tablet. Pain Pract. 2007 Dec;7(4):324-31. Epub 2007 Nov 6. PubMed PMID: 17986159.
76: Di Girolamo G, Opezzo JA, Lopez MI, Schere D, Keller G, Gonzalez CD, Massa
JM, de los Santos MC. Relative bioavailability of new formulation of paracetamol
effervescent powder containing sodium bicarbonate versus paracetamol tablets: a
comparative pharmacokinetic study in fed subjects. Expert Opin Pharmacother. 2007
Oct;8(15):2449-57. PubMed PMID: 17931082.
77: Wang L, Tang X. A novel ketoconazole bioadhesive effervescent tablet for
vaginal delivery: design, in vitro and ‘in vivo’ evaluation. Int J Pharm. 2008
Feb 28;350(1-2):181-7. Epub 2007 Aug 31. PubMed PMID: 17920795.
78: Getia M, Murtazashvili M, Bakuridze A, Jokhadze M, Kuchukhidze J. Production
of effervescent tablets Mucomali from polysaccharides of Malva Silvestris L.
Georgian Med News. 2007 Apr;(145):90-4. PubMed PMID: 17525511.
79: Wiwattanapatapee R, Chumthong A, Pengnoo A, Kanjanamaneesathian M.
Effervescent fast-disintegrating bacterial formulation for biological control of
rice sheath blight. J Control Release. 2007 Jun 4;119(2):229-35. Epub 2007 Feb 2.
PubMed PMID: 17428569.
80: Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000 mg effervescent
aspirin: individual patient data meta-analysis of three trials in migraine
headache and migraine accompanying symptoms. J Neurol. 2007 Jun;254(6):705-12.
Epub 2007 Apr 10. PubMed PMID: 17406776.
81: Hesaraki S, Moztarzadeh F, Sharifi D. Formation of interconnected macropores
in apatitic calcium phosphate bone cement with the use of an effervescent
additive. J Biomed Mater Res A. 2007 Oct;83(1):80-7. PubMed PMID: 17380498.
82: Zheng P, Wang WZ, Zhang P, Han J, Wu LZ. [Optimization of preparative
technique for banxia-houpu effervescent tablets by orthogonal design]. Zhong Yao
Cai. 2006 Oct;29(10):1087-90. Chinese. PubMed PMID: 17326411.
83: Stocchi F, Fabbri L, Vecsei L, Krygowska-Wajs A, Monici Preti PA, Ruggieri
SA. Clinical efficacy of a single afternoon dose of effervescent
levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease. Clin
Neuropharmacol. 2007 Jan-Feb;30(1):18-24. PubMed PMID: 17272966.
84: Hesaraki S, Sharifi D. Investigation of an effervescent additive as porogenic
agent for bone cement macroporosity. Biomed Mater Eng. 2007;17(1):29-38. PubMed
PMID: 17264385.
85: Ely L, Roa W, Finlay WH, Löbenberg R. Effervescent dry powder for respiratory
drug delivery. Eur J Pharm Biopharm. 2007 Mar;65(3):346-53. Epub 2006 Nov 7.
PubMed PMID: 17156987.
86: Parr MK, Geyer H, Hoffmann B, Köhler K, Mareck U, Schänzer W. High amounts of
17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary
supplement market. Biomed Chromatogr. 2007 Feb;21(2):164-8. PubMed PMID:
17146762.
87: Hesaraki S, Moztarzadeh F, Solati-Hashjin M. Phase evaluation of an
effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B
Appl Biomater. 2006 Nov;79(2):203-9. PubMed PMID: 16924623.
88: Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus
Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center
taste preference study. Paediatr Drugs. 2006;8(4):265-70. PubMed PMID: 16898856.
89: Darwish M, Tempero K, Kirby M, Thompson J. Relative bioavailability of the
fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal
fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a
single-dose, randomized, open-label, three-period study in healthy adult
volunteers. Clin Ther. 2006 May;28(5):715-24. PubMed PMID: 16861093.
90: Darwish M, Kirby M, Robertson P Jr, Tracewell W, Jiang JG. Pharmacokinetic
properties of fentanyl effervescent buccal tablets: a phase I, open-label,
crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult
volunteers. Clin Ther. 2006 May;28(5):707-14. PubMed PMID: 16861092.
91: Sung HH, Laborde-Kummer E, Gaudin K, Dubost JP. Development and validation of
a capillary electrophoresis method for the determination of sulfate in
effervescent tablets. Eur J Pharm Biopharm. 2006 Aug;64(1):33-7. Epub 2006 Jun 5.
PubMed PMID: 16750356.
92: Nielsen AF, Poul B, Kristensen HG, Kristensen J, Hovgaard L. Investigation
and comparison of performance of effervescent and standard pneumatic atomizer
intended for soluble aqueous coating. Pharm Dev Technol. 2006;11(2):243-53.
PubMed PMID: 16749535.
93: Stepanek F, Loo A, Lim TS. Multiscale modelling methodology for virtual
prototyping of effervescent tablets. J Pharm Sci. 2006 Jul;95(7):1614-25. PubMed
PMID: 16732565.
94: Good BT, Bowman CN, Davis RH. An effervescent reaction micropump for portable
microfluidic systems. Lab Chip. 2006 May;6(5):659-66. Epub 2006 Mar 20. PubMed
PMID: 16652182.
95: Darwish M, Tempero K, Kirby M, Thompson J. Pharmacokinetics and dose
proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
Clin Pharmacokinet. 2005;44(12):1279-86. PubMed PMID: 16372825.
96: Benting DG, Pesun IJ, Hodges J. Compliance of resilient denture liners
immersed in effervescent denture cleansers. J Prosthodont. 2005 Sep;14(3):175-83.
PubMed PMID: 16336235.
97: Hu L, Zheng J, Shao S. [Study on the preparation of effervescent tablets of
EGb and its quality]. Zhong Yao Cai. 2005 Jan;28(1):52-4. Chinese. PubMed PMID:
15934243.
98: Dinç E, Ozdemir A, Baleanu D. Comparative study of the continuous wavelet
transform, derivative and partial least squares methods applied to the
overlapping spectra for the simultaneous quantitative resolution of ascorbic acid
and acetylsalicylic acid in effervescent tablets. J Pharm Biomed Anal. 2005 Mar
9;37(3):569-75. Epub 2004 Dec 22. PubMed PMID: 15740918.
99: Lee J, Anderson R. Best evidence topic report. Effervescent agents for
oesophageal food bolus impaction. Emerg Med J. 2005 Feb;22(2):123-4. Review.
PubMed PMID: 15662067; PubMed Central PMCID: PMC1726678.
100: Munn S. The way to a man’s heart is through his stomach: much
‘diaphragmatic’ attenuation is likely gastric, and effervescent granules enhance
cardiac imaging. Eur J Radiol. 2004 Dec;52(3):271-5. Erratum in: Eur J Radiol.
2005 May;54(2):316. PubMed PMID: 15544905.
101: Tian XF, Bian BL. [Development of effervescent tablet of Chinese traditional
medicine and its technology study]. Zhongguo Zhong Yao Za Zhi. 2004
Jul;29(7):624-7. Review. Chinese. PubMed PMID: 15503761.
102: Dinç E, Ozdemir A. Multivariate spectral calibration technique based on
regression analysis for the quantitative multiresolution of a ternary mixture
containing paracetamol, ascorbic acid and acetylsalicylic acid in effervescent
tablets. Pharmazie. 2004 Sep;59(9):700-5. PubMed PMID: 15497752.
103: Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai
V, Göbel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller-Schwefe G, Nappi
G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M; EMSASI Study Group.
Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan
and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004
Nov;24(11):947-54. PubMed PMID: 15482357.
104: Rey E, Poves-Francés C, Sánchez G, Fueyo A, Badiola C, Díaz-Rubio M. Effects
of effervescent ranitidine on gastric pH: comparison with almagate and placebo in
fasting and postprandial conditions. Aliment Pharmacol Ther. 2004 Sep
15;20(6):683-8. PubMed PMID: 15352917.
105: Diener HC, Eikermann A, Gessner U, Göbel H, Haag G, Lange R, May A,
Müller-Schwefe G, Voelker M. Efficacy of 1,000 mg effervescent acetylsalicylic
acid and sumatriptan in treating associated migraine symptoms. Eur Neurol.
2004;52(1):50-6. Epub 2004 Jul 5. PubMed PMID: 15240983.
106: Li XD, Pan WS, Nie SF, Wu LJ. Studies on controlled release effervescent
osmotic pump tablets from Traditional Chinese Medicine Compound Recipe. J Control
Release. 2004 May 18;96(3):359-67. PubMed PMID: 15120893.
107: Petersen FJ, Wørts O, Schaefer T, Sojka PE. Design and atomization
properties for an inside-out type effervescent atomizer. Drug Dev Ind Pharm. 2004
Mar;30(3):319-26. PubMed PMID: 15109031.
108: Falk DJ, Heelan KA, Thyfault JP, Koch AJ. Effects of effervescent creatine,
ribose, and glutamine supplementation on muscular strength, muscular endurance,
and body composition. J Strength Cond Res. 2003 Nov;17(4):810-6. PubMed PMID:
14636104.
109: Sawyer M, Kumar V. A rapid high-performance liquid chromatographic method
for the simultaneous quantitation of aspirin, salicylic acid, and caffeine in
effervescent tablets. J Chromatogr Sci. 2003 Sep;41(8):393-7. PubMed PMID:
14558930.
110: Ganguly S, Jayappa S, Dash AK. Evaluation of the stability of creatine in
solution prepared from effervescent creatine formulations. AAPS PharmSciTech.
2003;4(2):E25. PubMed PMID: 12916907; PubMed Central PMCID: PMC2750587.
111: Ma YM, Qiu FR, Mao GG, Zeng ZH, Chen B, Sun H. [Relative bioavailability of
effervescent tablet of potassium chloride in healthy volunteers]. Yao Xue Xue
Bao. 2001 Sep;36(9):699-702. Chinese. PubMed PMID: 12580112.
112: Verschuren F, Thys F, Wittebole X, Janssens P, Elgariani A, Marion E, Meert
P, Wallemacq P, Hantson P, Reynaert M. Effervescent paracetamol poisoning: a case
report. Eur J Emerg Med. 2002 Dec;9(4):339-41. PubMed PMID: 12501034.
113: Zikán V, Roubal P, Stĕpán J. [Acute biochemical effects of calcium:
comparison of two dosage forms of calcium carbonate (powder and effervescent
tablets) and milk in healthy women]. Cas Lek Cesk. 2002 Mar 1;141(4):127-31.
Czech. PubMed PMID: 12046257.
114: Wildgrube HJ, Kierschke G, Nowak H, Weigmann I, Terhaag B. [Application of
quantifying scoring systems for the determination of changes in the mucosa of the
upper gastrointestinal tract. A comparative study of a diclofenac effervescent
tablet with conventional diclofenac preparations and acetylsalicylic acid after
repeated administration]. Arzneimittelforschung. 2002;52(4):264-72. German.
PubMed PMID: 12040969.
115: Karasulu HY, Taneri F, Sanal E, Güneri T, Ertan G. Sustained release
bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal
delivery. J Microencapsul. 2002 May-Jun;19(3):357-62. PubMed PMID: 12022501.
116: Jakus J, Kriska T, Vanyúr R. Effect of multivitamins in an effervescent
preparation on the respiratory burst of peritoneal macrophages in mice. Br J
Nutr. 2002 May;87(5):501-8. PubMed PMID: 12010588.
117: Belpois Duchamp C, Le Coq M, Bergeal E, Duez JM, Aho LS. Could an
effervescent tablet, prepared with contaminated [correction of contamined] water,
create an aerosol containing Legionella? J Hosp Infect. 2002 May;51(1):77. PubMed
PMID: 12009829.
118: Gohel MC, Sumitra G M. Modulation of active pharmaceutical material release
from a novel ‘tablet in capsule system’ containing an effervescent blend. J
Control Release. 2002 Feb 19;79(1-3):157-64. PubMed PMID: 11853927.
119: Park TG. Perfusion culture of hepatocytes within galactose-derivatized
biodegradable poly(lactide-co-glycolide) scaffolds prepared by gas foaming of
effervescent salts. J Biomed Mater Res. 2002 Jan;59(1):127-35. PubMed PMID:
11745545.
120: Van Poucke S, Hans G, Hens P. The release of dissolved gases from solution
during decompression after hyperbaric treatment: effervescent tables and Henry’s
law. Anesthesiology. 2001 Sep;95(3):816. PubMed PMID: 11575571.
121: Petersen FJ, Wørts O, Schaefer T, Sojka PE. Effervescent atomization of
aqueous polymer solutions and dispersions. Pharm Dev Technol. 2001;6(2):201-10.
PubMed PMID: 11416994.
122: Yanze MF, Duru C, Jacob M, Bastide JM, Lankeuh M. Rapid therapeutic response
onset of a new pharmaceutical form of chloroquine phosphate 300 mg: effervescent
tablets. Trop Med Int Health. 2001 Mar;6(3):196-201. PubMed PMID: 11299036.
123: Yoon JJ, Park TG. Degradation behaviors of biodegradable macroporous
scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 2001
Jun 5;55(3):401-8. PubMed PMID: 11255194.
124: Yanze FM, Duru C, Jacob M. Process to manufacture effervescent tablets: air
forced oven melt granulation. Pharmazie. 2000 Dec;55(12):919-24. PubMed PMID:
11189868.
125: Lange R, Schwarz JA, Hohn M. Acetylsalicylic acid effervescent 1000 mg
(Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind,
single-dose, placebo-controlled parallel group study. Cephalalgia. 2000
Sep;20(7):663-7. PubMed PMID: 11128825.
126: Terhaag B, Hoffmann A, Barkworth M, Vens-Cappell B. Bioavailability of a new
effervescent tablet of diclofenac. Int J Clin Pharmacol Ther. 2000
Nov;38(11):546-51. PubMed PMID: 11097147.
127: Yanze FM, Duru C, Jacob M. A process to produce effervescent tablets:
fluidized bed dryer melt granulation. Drug Dev Ind Pharm. 2000
Nov;26(11):1167-76. PubMed PMID: 11068690.
128: Earnest D, Robinson M, Rodriguez-Stanley S, Ciociola AA, Jaffe P, Silver MT,
Kleoudis CS, Murdock RH. Managing heartburn at the ‘base’ of the GERD ‘iceberg’:
effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief
than antacids. Aliment Pharmacol Ther. 2000 Jul;14(7):911-8. PubMed PMID:
10886047.
129: Săndulescu R, Mirel S, Oprean R. The development of spectrophotometric and
electroanalytical methods for ascorbic acid and acetaminophen and their
applications in the analysis of effervescent dosage forms. J Pharm Biomed Anal.
2000 Aug 1;23(1):77-87. PubMed PMID: 10898157.
130: Rygnestad T, Zahlsen K, Samdal FA. Absorption of effervescent paracetamol
tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J
Clin Pharmacol. 2000 May;56(2):141-3. PubMed PMID: 10877008.
131: Yanze MF, Duru C, Jacob M, Gasc F. [The carbon dioximeter: a device for
quantifying the carbon dioxide released from effervescent pharmaceuticals]. J
Pharm Belg. 2000 Mar-Apr;55(2):53-6. French. PubMed PMID: 10842927.
132: Møller PL, Nørholt SE, Ganry HE, Insuasty JH, Vincent FG, Skoglund LA,
Sindet-Pedersen S. Time to onset of analgesia and analgesic efficacy of
effervescent acetaminophen 1000 mg compared to tablet acetaminophen 1000 mg in
postoperative dental pain: a single-dose, double-blind, randomized,
placebo-controlled study. J Clin Pharmacol. 2000 Apr;40(4):370-8. PubMed PMID:
10761164.
133: Le Coz CJ, Bezard M. Allergic contact cheilitis due to effervescent dental
cleanser: combined responsibilities of the allergen persulfate and prosthesis
porosity. Contact Dermatitis. 1999 Nov;41(5):268-71. PubMed PMID: 10554061.
134: Krögel I, Bodmeier R. Floating or pulsatile drug delivery systems based on
coated effervescent cores. Int J Pharm. 1999 Oct 5;187(2):175-84. PubMed PMID:
10502623.
135: Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP,
Scarpignato C. Effects of tablet and effervescent formulations of ranitidine 75
mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in
healthy humans. Aliment Pharmacol Ther. 1998 Nov;12(11):1155-61. PubMed PMID:
9845405.
136: Elm M, Hellke P, Andrén K, Dahl G, Nyth AL. Time to relief of episodic
symptoms of gastro-oesophageal reflux disease. A crossover comparison of single
doses of the effervescent and standard formulations of ranitidine. Scand J
Gastroenterol. 1998 Sep;33(9):900-4. PubMed PMID: 9759942.
137: Rotthäuser B, Kraus G, Schmidt PC. Optimization of an effervescent tablet
formulation containing spray dried L-leucine and polyethylene glycol 6000 as
lubricants using a central composite design. Eur J Pharm Biopharm. 1998
Jul;46(1):85-94. PubMed PMID: 9700026.
138: Hedenström H, Alm C, Kraft M, Grahnén A. Intragastric pH after oral
administration of single doses of ranitidine effervescent tablets, omeprazole
capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Aliment Pharmacol Ther. 1997 Dec;11(6):1137-41. PubMed PMID: 9663842.
139: Reilly TG, Grimley CE, Usselmann B, Cottrell J, Mann SG, Raskin S, Nwokolo
CU. Low-dose famotidine and effervescent cimetidine in healthy subjects: a
placebo-controlled overnight pH study. Aliment Pharmacol Ther. 1998
May;12(5):469-74. PubMed PMID: 9663728.
140: Merckle P, Kovar KA. Assay of effervescent tablets by near-infrared
spectroscopy in transmittance and reflectance mode: acetylsalicylic acid in mono
and combination formulations. J Pharm Biomed Anal. 1998 Jul;17(3):365-74. PubMed
PMID: 9656145.
141: Eichman JD, Robinson JR. Mechanistic studies on effervescent-induced
permeability enhancement. Pharm Res. 1998 Jun;15(6):925-30. PubMed PMID: 9647360.
142: Wu CS, Yao WJ, Hsiao CH. Effervescent gallbladder: sonographic findings in
emphysematous cholecystitis. J Clin Ultrasound. 1998 Jun;26(5):272-5. PubMed
PMID: 9608373.
143: Berlin I, Decroix D, Molinier P, Herrmann MA, Peraudeau P, Scheck F.
[Comparison between effects of morning and evening administration of effervescent
calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa
in healthy volunteers]. Pathol Biol (Paris). 1997 Jun;45(6):514-20. French.
PubMed PMID: 9309270.
144: Engzelius JM, Solhaug JH, Knapstad LJ, Kjaersgaard P. Ranitidine
effervescent and famotidine wafer in the relief of episodic symptoms of
gastro-oesophageal reflux disease. Scand J Gastroenterol. 1997 Jun;32(6):513-8.
PubMed PMID: 9200279.
145: Arnestad JS, Kleveland PM, Waldum HL. In single doses ranitidine
effervescent is more effective than lansoprazole in decreasing gastric acidity.
Aliment Pharmacol Ther. 1997 Apr;11(2):355-8. PubMed PMID: 9146775.
146: Altomare E, Vendemiale G, Benvenuti C, Andreatta P. Bioavailability of a new
effervescent tablet of ibuprofen in healthy volunteers. Eur J Clin Pharmacol.
1997;52(6):505-6. PubMed PMID: 9342589.
147: Hummel T, Cramer O, Mohammadian P, Geisslinger G, Pauli E, Kobal G.
Comparison of the antinociception produced by two oral formulations of ibuprofen:
ibuprofen effervescent vs ibuprofen tablets. Eur J Clin Pharmacol.
1997;52(2):107-14. PubMed PMID: 9174679.
148: Watson RG, Johnston BT, Tham TC, Kersey K. Effervescent and standard
formulations of ranitidine–a comparison of their pharmacokinetics and
pharmacology. Aliment Pharmacol Ther. 1996 Dec;10(6):913-8. PubMed PMID: 8971288.
149: Kovács-Hadady K, Fábián I. Determination of vitamin C in effervescent
tablets containing other vitamins together with trace elements. J Pharm Biomed
Anal. 1996 Aug;14(11):1479-86. PubMed PMID: 8877853.
150: Propst A, Propst T, Judmaier G. Comparison of the effects of ranitidine
effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric
acidity. A single-centre, randomised, open cross-over study.
Arzneimittelforschung. 1996 Jun;46(6):621-4. PubMed PMID: 8767354.
151: Stacey JH, Miocevich ML, Sacks GE. The effect of ranitidine (as effervescent
tablets) on the quality of life of GORD patients. Br J Clin Pract. 1996
Jun;50(4):190-4, 196. PubMed PMID: 8759564.
152: Sun X, Zhang Z, Ma L, Zhang W. [Extraction technology of effervescent
granules for arresting cold pain optimized by orthogonal tests]. Zhongguo Zhong
Yao Za Zhi. 1996 Mar;21(3):159-61, 190. Chinese. PubMed PMID: 9206256.
153: Vatier J, Cai S, Slama A, Farinotti R. [Antacid activity of
citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro
analysis using ‘artificial stomach-duodenum’ model]. Therapie. 1996
Mar-Apr;51(2):139-46. French. PubMed PMID: 8763048.
154: Katare OP, Vyas SP, Dixit VK. Enhanced in vivo performance of liposomal
indomethacin derived from effervescent granule based proliposomes. J
Microencapsul. 1995 Sep-Oct;12(5):487-93. PubMed PMID: 8544092.
155: Levine MS. How concerned should radiologists be about perforating the
esophagus by administering an effervescent agent during a barium swallow to treat
a foreign body impacted in the distal esophagus? AJR Am J Roentgenol. 1995
Aug;165(2):480-1. PubMed PMID: 7618582.
156: Schütze K, Hentschel E, Happonen P, Akkila J. Sucralfate effervescent
tablet: treatment of peptic ulcer disease and change in serum aluminium
concentration. Hepatogastroenterology. 1995 Jul;42(3):240-5. PubMed PMID:
7590572.
157: Keller A, Fuhr U, Sauter R, Steinijans VW, Staib AH. [Pharmacokinetics of a
theophylline effervescent tablet]. Pharmazie. 1995 May;50(5):356-8. German.
PubMed PMID: 7604069.
158: Henry P, Hiesse-Provost O, Dillenschneider A, Ganry H, Insuasty J. [Efficacy
and tolerance of an effervescent aspirin-metoclopramide combination in the
treatment of a migraine attack. Randomized double-blind study using a placebo].
Presse Med. 1995 Feb 4;24(5):254-8. French. PubMed PMID: 7899379.
159: Smout AJ, Jonkman JH, Peeters PA, De Bruin H. Effect of an evening dose of
regular and effervescent formulations of ranitidine or cimetidine on intragastric
pH in healthy volunteers. Aliment Pharmacol Ther. 1995 Feb;9(1):51-6. PubMed
PMID: 7766744.
160: Sun X, Zhang Z, Liu Z, Zhang W. [Quality standards of effervescent granules
for the treatment of cold pain]. Zhongguo Zhong Yao Za Zhi. 1995 Jan;20(1):26-30,
62. Chinese. PubMed PMID: 7626205.
161: Sharma NK, Kindelan JD, Hutchinson D, Lancaster L. A study to compare
ibuprofen effervescent granules with ibuprofen tablets in the treatment of acute
dental pain. Prim Dent Care. 1994 Sep;1(1):5-8. PubMed PMID: 8941780.
162: Brady AP. Use of effervescent agents in small bowel meal examination. Clin
Radiol. 1994 Jun;49(6):434-5. PubMed PMID: 8045075.
163: Löser C, Burlage M, Fölsch UR. [The effect of ranitidine and famotidine on
the intragastric pH profile of healthy subjects. Randomized cross-over trial with
ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg)
]. Arzneimittelforschung. 1994 May;44(5):626-9. German. PubMed PMID: 8024636.
164: Robbins MI, Shortsleeve MJ. Treatment of acute esophageal food impaction
with glucagon, an effervescent agent, and water. AJR Am J Roentgenol. 1994
Feb;162(2):325-8. PubMed PMID: 8310919.
165: Viel C. [The effervescent baths and mercurial fumigations of Guietand, a
Paris pharmacist]. Rev Hist Pharm (Paris). 1994;41(301):149-53. French. PubMed
PMID: 11640372.
166: Griffiths PD, Hufton AP, Martin DF. The use of effervescent agents in the
small bowel meal examination. Clin Radiol. 1993 Oct;48(4):275-7. PubMed PMID:
8243008.
167: Klein HM, Günther RW. Double contrast small bowel follow-through with an
acid-resistant effervescent agent. Invest Radiol. 1993 Jul;28(7):581-5. PubMed
PMID: 8344806.
168: Grossi L, Di Felice F, Marzio L. [Efficacy and tolerability of cisapride in
a new formula of 10 mg effervescent capsules for the treatment of functional
dyspepsia]. Clin Ter. 1993 Jun;142(6):521-7. Italian. PubMed PMID: 8354045.
169: Hakata T, Iijima M, Okabe T, Kimura S, Sato H, Watanabe Y, Matsumoto M.
Methods of evaluation of release of carbon dioxide from effervescent
suppositories. Chem Pharm Bull (Tokyo). 1993 Feb;41(2):346-50. PubMed PMID:
8500200.
170: Grossi L, Di Felice F, Marzio L. [A new granular effervescent 10-mg
formulation of cisapride in the treatment of gastroesophageal reflux]. Clin Ter.
1993 Feb;142(2):127-33. Italian. PubMed PMID: 8472526.
171: Hakata T, Iijima M, Kimura S, Sato H, Watanabe Y, Matsumoto M. Effects of
bases and additives on release of carbon dioxide from effervescent suppositories.
Chem Pharm Bull (Tokyo). 1993 Feb;41(2):351-6. PubMed PMID: 8388785.
172: Hartmann B, Schmieder G, Tetzloff W, Töberich H. [Bioequivalence and
bioavailability after single administration of effervescent ranitidine tablets].
Arzneimittelforschung. 1992 Aug;42(8):1020-2. German. PubMed PMID: 1418073.
173: Bloom RA, Craciun E, Lebensart PD, Levy P, Ziv JB. The ultrasound
appearances of intramural bowel gas: the bright ring appearance and the
effervescent bowel. A report of three cases. Br J Radiol. 1992 Jul;65(775):585-8.
PubMed PMID: 1515895.
174: Main J, Ward MK. Potentiation of aluminium absorption by effervescent
analgesic tablets in a haemodialysis patient. BMJ. 1992 Jun 27;304(6843):1686.
PubMed PMID: 1633526; PubMed Central PMCID: PMC1882349.
175: Ducrotté P, Weber J, Colin R, Denis P. Effect of an effervescent
citrate-cimetidine combination on intragastric pH in healthy subjects. A
randomized, placebo-controlled three-period cross-over design. Gastroenterol Clin
Biol. 1992;16(2):162-5. PubMed PMID: 1568544.
176: Andersen MP. Lack of bioequivalence between disulfiram formulations.
Exemplified by a tablet/effervescent tablet study. Acta Psychiatr Scand Suppl.
1992;369:31-5. PubMed PMID: 1471549.
177: Vlasblom V, Fellinger HW, Breumelhof R, Smout AJ. Effects of a new
effervescent cimetidine formulation on gastric acidity in healthy subjects. Neth
J Med. 1991 Apr;38(3-4):147-52. PubMed PMID: 1881502.
178: Hu YZ. [Observations in vivo on spermicidal effect of nonoxynol-9
contraceptive in forms of effervescent suppository and film]. Zhonghua Fu Chan Ke
Za Zhi. 1991 Mar;26(2):100-2, 125. Chinese. PubMed PMID: 1650310.
179: Ström M, Madsen S, Norlander B. Intragastric pH rise with effervescent
citrate-cimetidine. Lancet. 1991 Feb 16;337(8738):433. PubMed PMID: 1671456.
180: Raab FJ, Taylor CA, Bucher JA, Mann BL. Scanning electron microscopic
examination of ultrasonic and effervescent methods of surface contaminant removal
from complete dentures. J Prosthet Dent. 1991 Feb;65(2):255-8. PubMed PMID:
2051361.
181: Ekman M, Reizenstein P, Teigen SW, Rønneberg R. Comparative absorption of
calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and
chloride solution. Bone. 1991;12(2):93-7. PubMed PMID: 2064846.
182: Dorhout Mees EJ, Basçi A. Citric acid in calcium effervescent tablets may
favour aluminium intoxication. Nephron. 1991;59(2):322. PubMed PMID: 1956499.
183: Coleman RE, Dirix LY, Dodwell D, Tubiana-Hulin M, Body JJ, Becher R, White
GK, Rubens RD, Van Oosterom A, Howell A, et al. Phase I/II evaluation of
effervescent and enteric coated oral pamidronate for bone metastases. Eur J
Cancer. 1991;27(7):945-6. PubMed PMID: 1834134.
184: Katare OP, Vyas SP, Dixit VK. Effervescent granule based proliposomes of
ibuprofen. J Microencapsul. 1990 Oct-Dec;7(4):455-62. PubMed PMID: 2266470.
185: Mangez JF, Rachet B, Beaumont D, Moore N, Winckler C. [The effect of
effervescent cimetidine as premedication on gastric acidity during elective
cesareans]. Cah Anesthesiol. 1990 May-Jun;38(3):169-71. French. PubMed PMID:
2207826.
186: Ormezzano X, Francois TP, Viaud JY, Bukowski JG, Bourgeonneau MC, Cottron D,
Ganansia MF, Gregoire FM, Grinand MR, Wessel PE. Aspiration pneumonitis
prophylaxis in obstetric anaesthesia: comparison of effervescent
cimetidine-sodium citrate mixture and sodium citrate. Br J Anaesth. 1990
Apr;64(4):503-6. PubMed PMID: 2334627.
187: Kaszar-Seibert DJ, Korn WT, Bindman DJ, Shortsleeve MJ. Treatment of acute
esophageal food impaction with a combination of glucagon, effervescent agent, and
water. AJR Am J Roentgenol. 1990 Mar;154(3):533-4. PubMed PMID: 2106216.
188: Schmidt PC, Christin I. [Effervescent tablets–a nearly forgotten drug
form]. Pharmazie. 1990 Feb;45(2):89-101. Review. German. PubMed PMID: 2187207.
189: Ormezzano X, Ganansia MF, Arnould JF, Gregoire FM, Wessel PE, Bourgeonneau
MC, Bukowski JC, Grinand MR, Viaud JY, N’Guyen NQ. [Prevention of aspiration
pneumonia in obstetrical anesthesia with the effervescent combination of
cimetidine and sodium citrate]. Ann Fr Anesth Reanim. 1990;9(3):285-8. French.
PubMed PMID: 2372156.
190: Arvouet-Grand A, Lejeune B, Pourrat A. [Dietetic use of red sugarbeet
pigment–effervescent tablets]. Pharm Acta Helv. 1990;65(9-10):275-9. French.
PubMed PMID: 2236183.
191: Caliceti P, Sartore L, Schiavon O, Veronese FM. Evaluation of proteolytic
enzymes in effervescent tablets. Boll Chim Farm. 1989 Sep;128(9):267-70. PubMed
PMID: 2699717.
192: Kaltwasser JP, Schwarz-van de Sand W. [Oral iron therapy. Bioavailability
and therapeutic effectiveness of ferrous iron in effervescent tablets in
posthemorrhagic iron deficiency anemia]. Dtsch Med Wochenschr. 1989 Aug
4;114(31-32):1188-95. German. PubMed PMID: 2666080.
193: Dévay A, Kovács P, Rácz I. [Formulation of effervescent tablets containing
acetylsalicylic acid. III. Investigation of the stability of the active
principles of tablets]. Acta Pharm Hung. 1989 Jan;59(1):11-5. Hungarian. PubMed
PMID: 2711837.
194: Huber J. [Clinical experiences with iron-folic acid substitution in
pregnancy in the form of an effervescent tablet]. Wien Med Wochenschr. 1988 Nov
30;138(22):574-7. German. PubMed PMID: 3213066.
195: Tokola RA. The effect of metoclopramide and prochlorperazine on the
absorption of effervescent paracetamol in migraine. Cephalalgia. 1988
Sep;8(3):139-47. PubMed PMID: 3197094.
196: Lim JH. The effervescent gallbladder. AJR Am J Roentgenol. 1988
Sep;151(3):612. PubMed PMID: 3044044.
197: Dévay A, Uderszky J, Rácz I. [Formulation of effervescent tablets containing
acetylsalicylic acid. I. Investigation of granulation parameters]. Acta Pharm
Hung. 1988 May;58(3):97-100. Hungarian. PubMed PMID: 3245450.
198: Dévay A, Kovács P, Rác Z. [Formulation of effervescent tablets containing
acetylsalicylic acid. II. Investigation of parameters of effervescent tablets].
Acta Pharm Hung. 1988 May;58(3):101-3. Hungarian. PubMed PMID: 2854354.
199: Reiff RL, White CL, Overman P, ElAttar T, Platt RD. Aspirin, buffered
aspirin, and effervescent buffer rinses in reducing gingival inflammation in
patients with gingivitis and early periodontitis. Quintessence Int. 1988
Apr;19(4):287-90. PubMed PMID: 3269579.
200: Fahr F, Kala H, Fries G, Helbig G. [Improvement of the solubility of problem
drugs. 18. Iomeglamic acid-PVA effervescent powder]. Pharmazie. 1988
Mar;43(3):217. German. PubMed PMID: 3380871.
201: Nemcek AA Jr, Gore RM, Vogelzang RL, Grant M. The effervescent gallbladder:
a sonographic sign of emphysematous cholecystitis. AJR Am J Roentgenol. 1988
Mar;150(3):575-7. PubMed PMID: 3277349.
202: Linkosalo E, Markkanen S, Alakuijala P, Seppä L. Effects of some commercial
health beverages, effervescent vitamin C preparations and berries on human dental
enamel. Proc Finn Dent Soc. 1988;84(1):31-8. PubMed PMID: 3362850.
203: Nyström E, Gustafsson I, Quiding H. The pain intensity at analgesic intake,
and the efficacy of diflunisal in single doses and effervescent acetaminophen in
single and repeated doses. Pharmacotherapy. 1988;8(3):201-9. PubMed PMID:
3050906.
204: ElAttar TM, Lin HS, Platt RD. Effect of effervescent buffered aspirin on
prostaglandin synthesis by human gingival fibroblasts. Prostaglandins Leukot Med.
1987 Oct;29(2-3):237-47. PubMed PMID: 2829238.
205: Joachim J, Kalantzis G, Delonca H, Sabatier R, Abramovici B, Lheritier J,
Molard F. [Effervescent aspartame tablets. II. The effect of granulometry and
temperature on effervescence time and the kinetics and rate of carbon dioxide
liberation]. J Pharm Belg. 1987 Sep-Oct;42(5):303-14. French. PubMed PMID:
3123639.
206: Pochaczevsky R. Double-contrast examination of the colon with carbon
dioxide: the use of effervescent powder. AJR Am J Roentgenol. 1987
Sep;149(3):502-4. PubMed PMID: 3113194.
207: Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent
zinc acetate lozenges to alter the course of upper respiratory tract infections
in Australian adults. Antimicrob Agents Chemother. 1987 Aug;31(8):1263-5. PubMed
PMID: 3307620; PubMed Central PMCID: PMC174915.
208: Coates D. Relative stability of sodium hypochlorite liquids and sodium
dichloroisocyanurate effervescent disinfectant tablets. J Hosp Infect. 1987
Jul;10(1):96-7. PubMed PMID: 2888821.
209: Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of
tension headache. A double-blind, placebo controlled study. Headache. 1987
Feb;27(2):90-5. PubMed PMID: 3553071.
210: Silver B, Sundholm EG. Solid-state esterification of codeine phosphate by
the acid constituent of effervescent tablets. J Pharm Sci. 1987 Jan;76(1):53-5.
PubMed PMID: 3585724.
211: Joachim J, Kalantzis G, Delonca H, Abramovici B, Lheritier J, Molard F.
[Effervescent aspartame tablets: influence of granulometry on the stress exerted
at the level of compression]. J Pharm Belg. 1987 Jan-Feb;42(1):17-28. French.
PubMed PMID: 3585684.
212: Joachim J, Kalantzis G, Joachim G, Delonca H, Maury L, Rambaud J.
[Sweeteners in effervescent forms: pharmaceutical and physical chemistry]. Pharm
Acta Helv. 1987;62(9):262-8. French. PubMed PMID: 3423095.
213: Meurman JH, Murtomaa H. Effect of effervescent vitamin C preparations on
bovine teeth and on some clinical and salivary parameters in man. Scand J Dent
Res. 1986 Dec;94(6):491-9. PubMed PMID: 3468598.
214: Joachim J, Kalantzis G, Jacob M, Mention J, Maury L, Rambaud J. [Technology
of effervescent granules. Physico-chemical study]. J Pharm Belg. 1986
Jul-Aug;41(4):197-208. French. PubMed PMID: 3783403.
215: Cameron AE, Power I, Hart AM. In vitro buffering capacity of Alka Seltzer
Effervescent. Anaesthesia. 1986 Jul;41(7):776-7. PubMed PMID: 3752455.
216: Sendall FE, Staniforth JN. A study of powder adhesion to metal surfaces
during compression of effervescent pharmaceutical tablets. J Pharm Pharmacol.
1986 Jul;38(7):489-93. PubMed PMID: 2875146.
217: Murrell GC, Rosen M. In vitro buffering capacity of Alka Seltzer
Effervescent. A comparison with magnesium trisilicate mixture B.P. and sodium
citrate 0.3 M. Anaesthesia. 1986 Feb;41(2):138-42. PubMed PMID: 3006533.
218: Wahl RL. Gastric xenon trapping mimicking COPD: recognition using an
effervescent agent. Eur J Nucl Med. 1986;12(3):155-7. PubMed PMID: 3758105.
219: Moriyasu F, Ban N, Nakamura T, Nishida O, Soh Y, Miura K, Sakai M, Takeda Y,
Miyake T, Uchino H. [Contrast effects of glucagon and effervescent granules on
gastrointestinal MRI (magnetic resonance imaging)]. Nihon Shokakibyo Gakkai
Zasshi. 1986 Jan;83(1):40-6. Japanese. PubMed PMID: 3084835.
220: Heir RS, Allsup VE. Metabolic alkalosis induced by effervescent
preparations. Lancet. 1985 Nov 23;2(8465):1182-3. PubMed PMID: 2865632.
221: Agha FP, Trenkner SW, Woolsey EJ, Hayes D. Comparison of two effervescent
agents for double-contrast upper gastrointestinal tract radiography. Radiology.
1985 Nov;157(2):533-4. PubMed PMID: 4048464.
222: Joachim J, Kalantzis G, Cordoba J, Joachim G, Delonca H. [Application of new
technology for effervescent tablets to different active principles]. J Pharm
Belg. 1985 Jul-Aug;40(4):229-36. French. PubMed PMID: 4067808.
223: Dévay A, Uderszky J, Tanay J, Nyitrai T, Sátori E, Rácz I. [Preclinical and
clinical pharmacokinetic study of orally administered effervescent
acetylsalicylic acid tablets]. Acta Pharm Hung. 1985 May;55(3):114-8. Hungarian.
PubMed PMID: 4036626.
224: Mohammed SH. Andrew’s liver salt as an effervescent in upper
gastrointestinal radiography. Gastrointest Radiol. 1985;10(4):336-8. PubMed PMID:
4054498.
225: Nishimura K, Sasahara K, Arai M, Nitanai T, Ikegami Y, Morioka T, Nakajima
E. Dosage form design for improvement of bioavailability of levodopa VI:
formulation of effervescent enteric-coated tablets. J Pharm Sci. 1984
Jul;73(7):942-6. PubMed PMID: 6088756.
226: Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin
(Migravess) versus effervescent aspirin or placebo for migraine attacks: a
double-blind study. Cephalalgia. 1984 Jun;4(2):107-11. PubMed PMID: 6375873.
227: Chen CT, Toung TJ, Haupt HM, Hutchins GM, Cameron JL. Evaluation of the
efficacy of Alka-Seltzer Effervescent in gastric acid neutralization. Anesth
Analg. 1984 Mar;63(3):325-9. PubMed PMID: 6703349.
228: Fraser GM, Preston PG. The small bowel barium follow-through enhanced with
an oral effervescent agent. Clin Radiol. 1983 Nov;34(6):673-9. PubMed PMID:
6424999.
229: Joachim J, Cordoba J, Joachim G, Delonca H. [A standard effervescent couple:
demonstration of a method for humid granulation and control of CO2 liberation]. J
Pharm Belg. 1983 Sep-Oct;38(5):251-7. French. PubMed PMID: 6422027.
230: Garnier R, Riboulet-Delmas G, Efthymiou ML. [Acute poisoning by a buffered
effervescent aspirin with vitamin C. Retrospective study of data from the Poison
Control Center of Paris 1974-1981]. Sem Hop. 1983 Apr 28;59(17):1313-6. French.
PubMed PMID: 6306811.
231: Ala-Hurula V. Bioavailability and antimigraine efficacy of effervescent
ergotamine. Headache. 1982 Jul;22(4):167-70. PubMed PMID: 6809690.
232: Ross-Lee LM, Elms MJ, Cham BE, Bochner F, Bunce IH, Eadie MJ. Plasma levels
of aspirin following effervescent and enteric coated tablets, and their effect on
platelet function. Eur J Clin Pharmacol. 1982;23(6):545-51. PubMed PMID: 7160424.
233: Armandou JP, Mattha AG. Establishment of a geographical and chronological
map for relative humidity (R.H.) in an effervescent tablets manufacturing and
storage building. Pharm Acta Helv. 1982;57(10-11):287-9. PubMed PMID: 7146031.
234: Anderson NR, Banker GS, Peck GE. Quantitative evaluation of pharmaceutical
effervescent systems II: Stability monitoring by reactivity and porosity
measurements. J Pharm Sci. 1982 Jan;71(1):7-13. PubMed PMID: 7057384.
235: Anderson NR, Banker GS, Peck GE. Quantitative evaluation of pharmaceutical
effervescent systems I: Design of testing apparatus. J Pharm Sci. 1982
Jan;71(1):3-6. PubMed PMID: 6276529.
236: El-Banna HM, Minina SA. The construction and uses of factorial designs in
the preparation of solid dosage forms. Part 1: Effervescent acetylsalicylic acid
tablets. Pharmazie. 1981 Jun;36(6):417-20. PubMed PMID: 7279987.
237: Blowers AJ, Cameron EG, Lawrence ER. Effervescent ergotamine tartrate
(Effergot) in the treatment of the acute migraine attack. Br J Clin Pract. 1981
May;35(5):188-90. PubMed PMID: 6794589.
238: Koehler RE, Weyman PJ, Stanley RJ, Lee JK, Balfe DM. Evaluation of three
effervescent agents for double-contrast upper gastrointestinal radiography.
Gastrointest Radiol. 1981;6(2):111-4. PubMed PMID: 7250624.
239: Helliwell M, Berry D. Theophylline absorption by effervescent activated
charcoal (Medicoal). J Int Med Res. 1981;9(3):222-5. PubMed PMID: 7238997.
240: Virkkunen P, Kreula J. Effervescent agents in the double contrast
examination of the stomach. Acta Radiol Diagn (Stockh). 1981;22(3A):261-5. PubMed
PMID: 6797260.
241: Van de Voort PL. Effervescent granules for the barium meal. Br J Radiol.
1980 Jun;53(630):608. PubMed PMID: 7426880.
242: Shannon IL. Evaluation of a 0.1% SnF2 mouth rinse prepared from an
effervescent tablet. J Pedod. 1980 Fall;5(1):29-39. PubMed PMID: 6938663.
243: Sena FJ, Piechocki JT, Li KL. Stability-indicating assay of acetaminophen in
an effervescent tablet by ion-pair high-performance liquid chromatography. J
Pharm Sci. 1979 Nov;68(11):1465-6. PubMed PMID: 512905.
244: Masters WH, Johnson VE, Kolodny RC, Tullman GD. In vivo evaluation of an
effervescent intravaginal contraceptive insert by simulated coital activity.
Fertil Steril. 1979 Aug;32(2):161-5. PubMed PMID: 572784.
245: de Lacey GJ, Wignall BK, Bray C. Effervescent granules for the barium meal.
Br J Radiol. 1979 May;52(617):405-8. PubMed PMID: 444838.
246: Orton D, Treharne Jones R, Kaspi T, Richardson R. Plasma salicylate levels
after soluble and effervescent aspirin. Br J Clin Pharmacol. 1979 Apr;7(4):410-2.
PubMed PMID: 444362; PubMed Central PMCID: PMC1429652.
247: Medicoal (effervescent activated charcoal) in the treatment of acute
poisoning. Drug Ther Bull. 1979 Jan 19;17(2):7-8. PubMed PMID: 759130.
248: Spitz HD. Determination of water in aluminum chlorohydrate and effervescent
tablets by Karl Fischer Analysis. J Pharm Sci. 1979 Jan;68(1):122-3. PubMed PMID:
758451.
249: Mertz DP. [The uric acid-lowering action of benzbromarone effervescent
granules and allopurinol. Comparative studies (author’s transl)]. MMW Munch Med
Wochenschr. 1978 Oct 20;120(42):1387-90. German. PubMed PMID: 101792.
250: Mugnier A. [Effervescent Paracetamol in odonto-stomatology for children].
Rev Odontostomatol (Paris). 1978 Jul-Aug;7(4):301-6. French. PubMed PMID: 281732.
251: Faguet JP, Duchĕne D, Puisieux F. [Tablets. 18. Influence of the method of
granulation and climatic conditions on the shelf life of effervescent sodium-free
acetylsalicylic acid tablets]. Pharm Acta Helv. 1978;53(7):197-204. French.
PubMed PMID: 733821.
252: Wainscott G, Kaspi T, Volans GN. The influence of thiethylperazine on the
absorption of effervescent aspirin in migraine. Br J Clin Pharmacol. 1976
Dec;3(6):1015-21. PubMed PMID: 22216523; PubMed Central PMCID: PMC1428962.
253: Broda H. [Bitter salt spring water from the Inowrocław Spa in the form of
effervescent tablets]. Pol Tyg Lek. 1976 Jul 12;31(28):1195-6. Polish. PubMed
PMID: 959032.
254: Johnson F, Gibbons DR. Microprocessors in health care: panacea or more
effervescent technology? Biomed Eng. 1976 Apr;11(4):132-6. PubMed PMID: 1276336.
255: Picha E. [Iron treatment by effervescent tablets (author’s transl)].
Geburtshilfe Frauenheilkd. 1975 Oct;35(10):792-5. German. PubMed PMID: 1102383.
256: Fascetti Testi P, Rosini S, Silvestri S. [Study of absorption, in man, of an
effervescent preparation N-acetyl-p-aminophenol (paracetamol)]. Farmaco Prat.
1975 Sep;30(9):437-44. Italian. PubMed PMID: 1183577.
257: Kovács I. [Procedure for the preparation of effervescent vaginal tablets for
veterinary use]. Acta Pharm Hung. 1975 Jul;45(4):160-6. Hungarian. PubMed PMID:
807083.
258: Villiaumey J, Faguet JP, Puisieux F, Mollet M, Chanzy MO. [Effervescent
aspirin without sodium. Preliminary clinical study]. Therapie. 1975
May-Jun;30(3):451-4. French. PubMed PMID: 1224366.
259: Volans GN. The effect of metoclopramide on the absorption of effervescent
aspirin in migraine. Br J Clin Pharmacol. 1975 Feb;2(1):57-63. PubMed PMID:
791318; PubMed Central PMCID: PMC1402484.
260: Faguet JP, Spingler E, Duchène D, Puisieux F. [Tablets. XVI. The influence
of humidity and temperature on the preservation of effervescent tablets]. Pharm
Acta Helv. 1975;50(9):251-61. French. PubMed PMID: 1178722.
261: Volans GN. Absorption of effervescent aspirin during migraine. Br Med J.
1974 Nov 2;4(5939):265-8. PubMed PMID: 4425854; PubMed Central PMCID: PMC1612218.
262: Hedges A, Kaye CM, Maclay WP, Turner P. A comparison of the absorption of
effervescent preparations of paracetamol and penicillin V
(phenoxymethylpenicillin) with solid dose forms of these drugs. J Clin Pharmacol.
1974 Jul;14(7):363-8. PubMed PMID: 4210848.
263: Volans GN. Effects of food and exercise on the absorption of effervescent
aspirin. Br J Clin Pharmacol. 1974 Apr;1(2):137-41. PubMed PMID: 22454900; PubMed
Central PMCID: PMC1402447.
264: Mathieu L. [Clinical trial in odontostomatology of a combination of
paracetamol and ascorbic acid in effervescent form]. Rev Odontostomatol (Paris).
1974 Mar-Apr;3(2):169-76. French. PubMed PMID: 4619215.
265: Aiache JM. [Effervescent tablets]. Pharm Acta Helv. 1974;49(5-6):169-77.
French. PubMed PMID: 4445187.
266: Gädeke R, Sander C, Schmidt P, Steinitz H. [Scope of usability, tolerance
and blood levels of potassium phenoxymethyl penicillin effervescent tablets in
children]. Med Klin. 1972 Sep 15;67(37):1173-5. German. PubMed PMID: 4628131.
267: Ali SL. [Citric acid determination in calcium-vitamin C effervescent
tablets]. Arch Pharm (Weinheim). 1972 Mar;305(3):219-21. German. PubMed PMID:
5048249.
268: [Kalk-xitix. Effervescent tablets for the prevention and treatment of
vitamin C and calcium deficiency symptoms]. Med Monatsschr. 1971 Oct;25(10):482.
German. PubMed PMID: 5122451.
269: Mielck W. [Marfluan–an effervescent dentifrice salt with myrrh]. Dent
Dienst. 1970 Nov;22(11):21. German. PubMed PMID: 5277612.
270: Lindberg NO. Preparation of effervescent tablets containing nicotinic acid
and sodium bicarbonate. Acta Pharm Suec. 1970 Feb;7(1):23-8. PubMed PMID:
5450401.
271: Murray RB. New approach to the fusion method for preparing granular
effervescent products. J Pharm Sci. 1968 Oct;57(10):1776-9. PubMed PMID: 5684752.
272: Neri G. [Vaginal effervescent suppositories with a fatty base]. Boll Chim
Farm. 1967 Nov;106(11):783-6. Italian. PubMed PMID: 5629419.
273: MATES J, SADILEK L. [THE SPECIFIC EFFECTS OF EFFERVESCENT CARBON DIOXIDE
BATH]. Fysiatr Revmatol Vestn. 1965 Jun;43:149-56. Czech. PubMed PMID: 14331077.
274: Amacker P. [Study on the preparation and determination of effervescent
tablets with essences (for inhalations and gargles)]. Pharm Acta Helv. 1965
Jun;40(6):345-60. French. PubMed PMID: 5867997.
275: Ducas J, Vert P, Steffann J, Thiriet M. [Use in pediatrics of an
effervescent derivative of prednisolone]. Ann Med Nancy. 1965 May;4:519-26.
French. PubMed PMID: 5830248.
276: García Otero V, García Fernández JL, Pescador del Hoyo L. [Results obtained
with effervescent potassium in the treatment of definite myocardial changes]. Rev
Esp Cardiol. 1965 Apr;18(2):238-50. Spanish. PubMed PMID: 5834379.
277: WEIL L, MATES J. [CONCENTRATION OF CARBON DIOXIDE IN INSPIRED AIR FOLLOWING
EFFERVESCENT BATHS]. Fysiatr Revmatol Vestn. 1965 Feb;43:12-5. Czech. PubMed
PMID: 14276722.
278: COLETTA V, KENNON L. NEW PREPARATIVE TECHNIQUE FOR EFFERVESCENT PRODUCTS. J
Pharm Sci. 1964 Dec;53:1524-5. PubMed PMID: 14255137.
279: RUBIN IC. A simplified light-weight apparatus for kymographic uterotubal
insufflation, with an effervescent tablet as source of carbon dioxide. J Am Med
Assoc. 1955 Nov 19;159(12):1190-2. PubMed PMID: 13263166.
280: EFFERVESCENT baths. Br J Phys Med. 1953 May;16(5):102-3. PubMed PMID:
13042049.
281: LOLLI G, SMITH R. Effervescent mixtures as adjuvants to the rapid absorption
of ingested drugs. N Engl J Med. 1946 Jul 18;235:80-4. PubMed PMID: 20991530.
282: JONES GK. Effervescent granular preparations. Manuf Chem Aerosol News. 1946
May;17:190-2. PubMed PMID: 20985315.